stocks index  markets index bulletin us employment costs up  in second quarter » us economicgrowth rate picks up secondquarter gdp  » investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aus gdp accelerates to  in second quarter achevrons stock slips  premarket after q results amcconnell blames democrats after healthcare loss  house approves borderwall money achevron q revenue  bln vs  bln a year ago factset consensus  bln achevron q factset eps consensus  cents achevron q eps includes charges of  mln and gains from asset sales of  mln ayear treasury yield down by  basis point to  asp  futures down  at  abreakingus stock futures trim losses after gdp data anasdaq futures down  at  adow futures off  at  ayear treasury yield down by  basis point to  achevron q eps  cents vs pershare loss  cents ayear treasury yield down by  basis points to  aaugust gold rises  at oz atreasury yields tick lower after secondquarter gdp data abreakinggold climbs after first read of secondquarter gdp ahpe ceo meg whitman says she won’t be uber’s next ceo aus dollar holds weakness following gdp data acorrectedget ready for the lessprofitable amazon that you used to know loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  ra pharmaceuticals k apr    pm  seeking alphasign in  join nowgo»ra pharmaceuticals rarxform k  current reportapr    pmabout ra pharmaceuticals rarxview as pdf ra pharmaceuticals inc form k received       united states securities and exchange commission washington dc      form k       current report pursuant to section  or d of the securities exchange act of    date of report date of earliest event reported april       ra pharmaceuticals inc exact name of registrant as specified in its charter     delaware       state or other jurisdiction of incorporation   commission file number   irs employer identification no    cambridge park drive cambridge ma    address of principal executive offices   zip code   registrants telephone number including area code     not applicable former name or former address if changed since last report     check the appropriate box below if the form k filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions   o written communications pursuant to rule  under the securities act  cfr      o soliciting material pursuant to rule a under the exchange act  cfr a     o precommencement communications pursuant to rule db under the exchange act  cfr db     o precommencement communications pursuant to rule ec under the exchange act  cfr ec         item          regulation fd disclosure   ra pharmaceuticals inc the company is furnishing a corporate presentation attached as exhibit  to this current report on form k which the company intends to use from time to time in meetings with investors and others beginning on april   the corporate presentation will also be available on the companys website at httprapharmacomsciencepresentationsandpublications   the information in this item  and exhibit  attached hereto shall not be deemed filed for purposes of section  of the securities and exchange act of  as amended or otherwise subject to the liabilities of that section nor shall they be deemed incorporated by reference in any filing under the securities act of  as amended except as expressly set forth by specific reference in such filing   item          financial statements and exhibits   d exhibits   exhibit no   description          ra pharmaceuticals inc corporate presentation      signatures   pursuant to the requirements of the securities exchange act of  the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized   date april   ra pharmaceuticals inc         by s david c lubner     david c lubner     executive vice president and chief financial officer      exhibit index   exhibit no   description          ra pharmaceuticals inc corporate presentation    exhibit  next generation therapeutics for disorders of complement regulation april  click to enlarge   forward looking statements this presentation contains forwardlooking statements within the meaning of the private securities litigation reform act of  including but not limited to statements regarding the safety efficacy and regulatory and clinical progress of our product candidates including ra all such forwardlooking statements are based on managements current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forwardlooking statements these risks and uncertainties include the risks that ra pharmas product candidates including ra will not successfully be developed or commercialized as well as the other factors discussed in the risk factors section in ra pharmas most recently filed annual report on form k as well as other risks detailed in ra pharmas subsequent filings with the securities and exchange commission there can be no assurance that the actual results or developments anticipated by ra pharma will be realized or even if substantially realized that they will have the expected consequences to or effects on ra pharma all information in this presentation is as of the date of the release and ra pharma undertakes no duty to update this information unless required by law  click to enlarge   overview focused on complementmediated diseases  addressing rare hematologic renal neurologic indications as well as ocular and autoimmune lead clinical program ra for paroxysmal nocturnal hemoglobinuria pnh  potent synthetic macrocyclic peptide inhibitor of complement c distinct binding site vs eculizumab  convenient selfadministered subcutaneous dosing  completed phase  safety pk and pd study in healthy volunteers rapid sustained near complete suppression of hemolysis and complement activity  received orphan drug designation from european medicines authority ema  phase  regulatory clearance from fda and exus agencies institutional review board irb approvals received site activation underway dosing to commence shortly powerful proprietary drug discovery engine  enables application to diseases with high unmet medical need andor for which only mabs have previously been successful  delivered orallyavailable peptides for a noncomplement cardiovascular target with a large market opportunity in our collaboration with merck  million in cash and cash equivalents as of december     million gross proceeds raised in october  initial public offering   click to enlarge   leadership team doug treco phd cofounder president and ceo ramin farzanehfar md chief medical officer david lubner evp chief financial officer simon read phd chief scientific officer alonso ricardo phd svp head of research jack w szostak phd cofounder  click to enlarge   pipeline  developing an extended release formulation to allow for potential weekly dosing  leveraging preclinical cmc and phase  data packages to advance ra in rmg and ln  c inhibition discovery preclinical phase  phase  ra pnh sc  ra refractory myasthenia gravis sc  ra lupus nephritis sc  oral small molecule inhibitor pnh rmg ln cns diseases factor d inhibition dry amdga intravit orphan renal diseases sc c inhibition autoimmunecns diseases partnered program noncomplement target oral macrocyclic peptide cardiovascular target with a large market opportunity click to enlarge   q ra phattna the complement pathway a targetrich opportunity for leveraging our proprietary platform alternative pathway classical pathway lectin pathway activated by nonself cells activated by antibodyantigen complexes activated by pathogen surfaces cciq··c··c ·· c af factor b ccc csa proinflammatory cytokine c pnh rupture of rbc cb ccc eculizumab bindscs ra binds cs  csb rmgdestruction of neuromuscular junction mac  ln inflammation of kidney glomerulus factor targeted by ra pharma product candidates  ra blocks cs cleavage and production of ca and cbsame outcome as eculizumab supports similar clinical efficacy blocks interaction of cb with c and mac formationunique property may be beneficial in hypercoagulative and inflammatory states where thrombin and other proteases can cleave cs click to enlarge   our extreme diversity platform  click to enlarge   mrna display platform a new approach to building druglike peptide libraries and nonnatural amino cyclize to create macrocyclic peptides convert mrna to cdna large and diverse library of macrocycle peptidecdna fusions large and diverse library of peptidemrna fusions p p affinity selection to immobilized target translation of mrna to peptides to create peptidemrna fusion mrna library with  puromycin p p p copy dna into mrna and attach puromycin pcr amplify cdna to produce large quantities of corresponding dna macrocyclic peptidecdna fusions bound to immobilized target sequence dna and synthesize peptide candidates optimize hits dna corresponding to selected peptides  drug lead candidate peptides translation with natural acids and cyclization to increase stability potency cell permeability and bioavailability rapid lead generation capabilities utility filling unmet needs associated with current monoclonal antibody biologic and peptide therapies  ability to distinguish between closely related targets  modulators of the undruggable proteome disrupt intracellular proteinprotein interactions click to enlarge   ra in paroxysmal nocturnal hemoglobinuria pnh  click to enlarge   ra paroxysmal nocturnal hemoglobinuria pnh rare chronic acquired hematologic syndrome where red blood cells rbcs are destroyed by the complement system  patients worldwide results in death of  of patients within  years and  within  years of diagnosis  most common cause of mortality is thrombosis only  approved therapy anticomplement c monoclonal antibody eculizumab soliris® alexion  biweekly iv infusion  approved for pnh and atypical hemolytic uremic syndrome ahus   revenues b straightforward clinical endpoints  markers of hemolysis hemoglobin levels transfusion requirements  strong correlation between level of hemolysis suppression and clinical benefit  click to enlarge   ra binds a site on c that is distinct from eculizumab ra binds in this region   distinct from eculizumab binding siteallows treatment of patients with rhc mutations  peptides targeting novel druggable sites provide a toolkit for developing true small molecule inhibitors of c click to enlarge   ra clinical development overview phase  placebocontrolled singleascending dose and multiple dose study in healthy volunteers completed q  highly predictable pk after single and multiple sc injections with dose dependent exposure  suppression of ex vivo hemolysis and complement activity was rapid nearcomplete and sustained  single and repeat doses of ra were well tolerated in healthy volunteers openlabel phase  global program in up to  patients  naïve patients patients who are currently treated with eculizumab and patients who respond inadequately to eculizumab  regulatory clearance and irb approvals received site activation underway  dosing to commence shortly data readouts planned midyear and yearend  plan to pursue other indications refractory myasthenia gravis rmg and lupus nephritis ln in parallel        oc for pd effects hv  pnh pts ph  extension planned mg ph b ln  ph   plan p prot plan ph p ned ocol ph  ned click to enlarge   ra phase  study singleascending dose cohorts in healthy volunteers randomized placebocontrolled doubleblind safety and dose finding study in healthy volunteers n  hours inpatient monitoring cohort  n ra n placebo cohort  n ra n placebo cohort  n ra n placebo cohort  n ra n placebo one center australia  mgkg mgkg mgkg mgkg ciprofloxacin prophylaxis cipro  neisseria vaccination  week follow up to assess safety and collect pkpd data click to enlarge   ra pharmacokinetics predictable dosedependent exposure after single sc injections linear relationship observed between cmax and dose level approximate terminal halflife across all cohorts is  days ra pharmacokinetics consistent with predicted values from in silico pk model generated using data from nonhuman primate nhp studies    actual drug levels in vivo n  mgkg or   mgkg per group      m g  k g    m g  k g    m g  k g    m g  k g click to enlarge   ra pharmacodynamics strong suppression of hemolysis and complement activity after single sc injections direct hemolysis after a single dose ra exhibited a rapid dosedependent inhibition of ex vivo hemolysis and suppression of complement activity in all subjects maximum pd effect observed h to  h after dosing a single dose of ra at  mgkg resulted in  suppression of hemolysis for at least  days in some subjects sustained inhibition of hemolysis at highest dose suggests possibility of less frequent dosing mac immunoassay     ch     m g  k g    m g  k g    m g  k g    m g  k g     m g  k g    m g  k g    m g  k g    m g  k g        m g  k g    m g  k g    m g  k g        m g  k g     n  mgkg or   mgkg permgrgo kugp s i s o l y s i s e m o l y s i s click to enlarge   ra phase  study multipledose cohort in healthy volunteers randomized doubleblind placebocontrolled multipledose study of safety pk and pd in healthy volunteers  daily doses  days inpatient monitoring n placebo n  mgkg n one center australia  ciprofloxacin prophylaxis  neisseria vaccination  week follow up to assess safety and collect pkpd data randomize click to enlarge   ra pk model predicts plasma drug levels in phase  multipledose cohort modeling of nonhuman primates nhp and human healthy volunteer pk data accurately predicted observed results consistent pharmacokinetics across all subjects with minimal variability in exposure at a  mgkg dose level ra concentrations in plasma are expected to reach steadystate by day  without a loading dose    model vs actual mean plasma ra levels n  click to enlarge   ra pharmacodynamics robust suppression of hemolytic activity in phase  multipledose cohort suppression of hemolysis and complement activity was rapid nearcomplete and sustained across the dosing period in all subjects inhibition of hemolysis activity at d h after receiving the last dose was observed to be  in all subjects hemolysis activity returned to predose levels within two weeks following the last dose    n placebo or   mgkg ra dosed daily per group  click to enlarge   ra protects against complementmediated hemolysis of type dose response iii pnh erythrocytes drug concentration no drug ra no drug eculizumab flow cytometry serum serum  hcl  eculizumab  μm serum  hcl  ra  μm serum  hcl type iii type iii h incubation of pnh rbcs with  acidified serum pnh rbcs provided by dr jaroslaw maciejewski  approx  μm  or ecu note ecu is bivalent click to enlarge   ra summary ra is a potent inhibitor of complement c designed for convenient daily subcutaneous selfadministration single and repeat sc doses of ra were well tolerated in healthy volunteers ra displayed dosedependent exposure and consistent and predictable pharmacokinetics which were highly correlated with its pharmacodynamic effect inhibition of hemolysis in ex vivo rbc lysis assay the findings from singleand multidose administration studies confirm that daily dosing with ra can achieve nearcomplete suppression of complement activity and hemolysis     phase  trial in pnh patients eculizumabnaïve and eculizumabtreated will commence dosing shortly with data readouts planned midyear and yearend  received a positive opinion for orphan drug designation from ema comp for ra for the treatment of pnh    click to enlarge   ra pnh planned phase  design goal to evaluate the safety tolerability efficacy pharmacokinetics and pharmacodynamics of ra in subjects with pnh  design openlabel  weeks with longterm extension  global program addressing  pnh populations  eculizumab naïve  eculizumab switch  eculizumab inadequate responders  primary efficacy endpoint change in lactate dehydrogenase ldh   click to enlarge   ra planned phase  design d w w w cohort a naïve n review of safety  efficacy mgkg loading dose evaluation period for primary efficacy endpoint change in ldh from baseline to mean of w w extension study d w w cohort b switch n review of safety  efficacy mgkg loading dose evaluation period for primary efficacy endpoint change in ldh from baseline to mean of w d w w w inadequate responders ldh   x uln n extension study review of safety  efficacy mgkg loading dose evaluation period for primary efficacy endpoint change in ldh from baseline to mean of w  mg kg qd mgkg qd or uptitrate to mgkg united states mg kg qd mgkg qd or uptitrate to mgkg mg kg qd mgkg qd or uptitrate to mgkg row click to enlarge   daily dosing allows maintenance of a stable drug level as compared to bolus biweekly dosing daily administration greatly reduces risk of drop in plasma drug levels below minimally efficacious level daily dosed drug weekly dosed drug minimum level needed to prevent hemolysis    day  plasma drug levels bi click to enlarge   ra potential advantages of a macrocyclic peptide inhibitor of c highly predictable pk robust pd effects  linear relationship between dose and cmax  observed from phase  data to maintain  hemolysis suppression at  hours after last dose  weekly dosing considered feasible improved control of hemolysis daily vs highdose biweekly iv infusion  sustained suppression dosing designed for continuous suppression vs bolus iv and decay over  weeks subcutaneous route of administration vs iv  improved quality of life inconvenience and lack of freedom associated with iv infusion  reduced complications of iv infusion infection venous access thrombosis comfort of ports  reduced treatment costs and reduced timeeconomic losses associated with homeclinic infusion expanded target population distinct binding site vs eculizumab  treatment of patients with rhc mutations synthetic product nonrecombinant  nonbiologic essentially no risk of contamination by viruses and animal cell products  treat patients with hypersensitivity to choderived products novel mechanistic feature vs eculizumab  potential to reduce complement damage mediated by other pathways        click to enlarge   ra a welldifferentiated profile for treating pnh protein monthly significant lft high doses not adequate for fcrn and c for technology increased risks of infection and insufficient increased risk technology potential to soliris targeting liver c for missed doses saturation of hemolysis doses fcrn additional pnh programs amgen biosimilar regeneron preclinical  ra alncccoversinalxnlfgroaplach chemistry target administration frequency stage rhc mutations comments cyclic peptide c sc daily weekly phase  ready rapidly and potently inhibits hemolysis convenient dosing favorable pk rnaitick salivamabmabmabcyclic peptide small molecule liver c mrnacccccfactor d scsciv sc iviv scscoral weeklymonthlyx dailyevery weeksbiweeklyunknowndailyx daily phphphphphphph extremelynot adequate monotherapyshort halflifefcrnsweepingmonotherapyliability in ph immunogenicityrecyclingsimilar profile inhibition fromno safety marginpotentialof infection onlysaturation offcrnvery highbreakthrough click to enlarge   complement regulation pipeline  click to enlarge   building a complement inhibitor franchise technology enables development of a portfolio of c inhibitor candidates suitable for chronic or acute indications  can vary pk properties and route of administration  allows different pricing structures for different indications life cycle extension plan for c inhibitors  weekly depot formulation  druggability of ra binding site has been used to identify true small molecule inhibitors of c leveraging ra preclinical cmc and phase  data packages to efficiently pursue other indications in parallel    lupus nephritis ln refractory myasthenia gravis rmg  ln affects approximately  patients in the united states approximately  will develop endstage renal disease requiring a kidney transplant or initiation of dialysis  rmg affects approximately  patients in the united states current therapies do not target injury caused by complement attack inhibiting terminal complement activity may block complementmediated damage     binding c may prevent progression of kidney disease in ln by blocking complementmediated damage to kidney cells applying mrna display platform to other targets factor d c  dry amdga orphan renal diseases ddd and cgn autoimmunecns diseases   click to enlarge   next generation of c inhibitors orally bioavailable small molecules series of orally bioavailable f small molecules that bind c inhibit its cleavageactivation ic  nm in sheep rbc lysis assay and prevent hemolysis of pnh erythrocytes in a dose dependent manner  serum  hcl  eculizumab serum  hcl  rax serum serum  hcl type iii type iii rax concentration high resolution cocrystal structures of sm inhibitors bound to c available  complete understanding of mechanism of action  enables structureguided optimization h incubation of pnh rbcs with  acidified serum pnh rbcs provided by dr jaroslaw maciejewski   click to enlarge   therapeutic use of factor d inhibitors factor d fd is a critical mediator of alternative pathway activation cleaves factor b bound to cb generating c convertase cbbb   fd potential indications  dense deposit diseasemembranoproliferative glomerulonephritis type iic glomerulopathy high priority uncontrolled activation of alternative pathway results in glomerular c deposition mutationspolymorphisms in complement genes associated with increased risk dry agerelated macular degeneration high priority polymorphism in complement regulatory factor h is risk factor for amd positive ph  data in geographic atrophy with antifactor d lampalizumab roche extravascular hemolysis in pnh patients treated with c inhibitor lower priority reduce c fragment coating on pnh rbcs and subsequent spleen phagocytosis extravascular hemolysis evh potential for increased risk of infection may limit investigator interest     klein r et al science   click to enlarge   factor d developing multiple molecules for two potential value streams highly potent inhibitors low nanomolar physical properties solubility and stability pbs plasma and log d etc vitreous in vitro dmpk microsomes retinal pigmented epithelium stability cyp profile including retinal cyps intravitreal dry amd low plasma stability lipophilic vitreal solubility microsomal and rpe stability systemicsubq dddcgn high plasma stability  click to enlarge   selective inhibition of the classical pathway c macrocycle project c complex and subunits multiple approaches to inhibition of c complex  cq has an emerging number of noncomplement functions  clearance of apoptotic cells and immunogenic debris  tolerance induction in dendritic cells  antiproliferative effect on tcells and inhibition of bcell signaling  ra macrocycle selections have targeted cs specific and dual cscr binding peptides to potentially avoid broad noncomplement effects of cq  preclinical evaluation underway  potential indications and competition  indication incidence competitionstatus cold agglutinin disease  in  antics tnt truenorth  ph soliris alexion  ph warm autoimmune hemolytic anemia  in  antics tnt truenorth  ph fostamatinib rigeloral syk inhibitor  ph rituximab roche  ph neurodegenerative disease ad hd als gbs eg ad  million in us as of  anticq annexon  preclinical click to enlarge   financial summary  million in cash and cash equivalents as of december     million gross proceeds raised in october  initial public offering   million net proceeds  collaboration with merck represents opportunity for additional milestone and royalty payments  delivered orallyavailable cyclic peptides for a noncomplement cardiovascular target with a large market opportunity now in development at merck m received to date with additional potential milestones of up to m and royalties    click to enlarge   upcoming clinical milestones regulatory and irb approval for phase  pnh program q site activation for phase  pnh program h commence dosing for phase  pnh program q data readouts for phase  pnh program midand ye  initiate phase  study in rmg h initiate phase  study in ln h  click to enlarge   investment highlights focused on complementmediated diseases  addressing rare hematologic renal neurologic indications as well as ocular and autoimmune lead clinical program ra for paroxysmal nocturnal hemoglobinuria pnh  potent synthetic macrocyclic peptide inhibitor of complement c distinct binding site vs eculizumab  convenient selfadministered subcutaneous dosing  completed phase  safety pk and pd study in healthy volunteers rapid sustained near complete suppression of hemolysis and complement activity  received orphan drug designation from european medicines authority ema  phase  regulatory clearance from fda and exus agencies irb approvals received site activation underway dosing to commence shortly powerful proprietary drug discovery engine  enables application to diseases with high unmet medical need andor for which only mabs have previously been successful  delivered orallyavailable peptides for a noncomplement cardiovascular target with a large market opportunity in our collaboration with merck     million in cash and cash equivalents as of december     million gross proceeds raised in october  initial public offering   click to enlarge   contact jen robinson senior director investor relations  corporate communications jrobinsonrapharmacom  click to enlarge   stocks index  markets index bulletin us employment costs up  in second quarter » us economicgrowth rate picks up secondquarter gdp  » investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aus gdp accelerates to  in second quarter achevrons stock slips  premarket after q results amcconnell blames democrats after healthcare loss  house approves borderwall money achevron q revenue  bln vs  bln a year ago factset consensus  bln achevron q factset eps consensus  cents achevron q eps includes charges of  mln and gains from asset sales of  mln ayear treasury yield down by  basis point to  asp  futures down  at  abreakingus stock futures trim losses after gdp data anasdaq futures down  at  adow futures off  at  ayear treasury yield down by  basis point to  achevron q eps  cents vs pershare loss  cents ayear treasury yield down by  basis points to  aaugust gold rises  at oz atreasury yields tick lower after secondquarter gdp data abreakinggold climbs after first read of secondquarter gdp ahpe ceo meg whitman says she won’t be uber’s next ceo aus dollar holds weakness following gdp data acorrectedget ready for the lessprofitable amazon that you used to know loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin us employment costs up  in second quarter » us economicgrowth rate picks up secondquarter gdp  » investor alert new york markets open in market snapshot analyst ratings stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aus gdp speeds up to  in nd quarter achevrons stock slips  premarket after q results amcconnell blames democrats after healthcare loss  house approves borderwall money achevron q revenue  bln vs  bln a year ago factset consensus  bln achevron q factset eps consensus  cents achevron q eps includes charges of  mln and gains from asset sales of  mln ayear treasury yield down by  basis point to  asp  futures down  at  abreakingus stock futures trim losses after gdp data anasdaq futures down  at  adow futures off  at  ayear treasury yield down by  basis point to  achevron q eps  cents vs pershare loss  cents ayear treasury yield down by  basis points to  aaugust gold rises  at oz atreasury yields tick lower after secondquarter gdp data abreakinggold climbs after first read of secondquarter gdp ahpe ceo meg whitman says she won’t be uber’s next ceo aus dollar holds weakness following gdp data acorrectedget ready for the lessprofitable amazon that you used to know loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft rarx  stock quote for ra pharmaceuticals inc  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices ra pharmaceuticals inc nasdaq rarx us markets open in min adchoices  ▼   after hours     july    pm edt delayed  minutes nasdaq currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news key executives for ra pharmaceuticals inc bloomberg  days ago company overview of ra pharmaceuticals inc bloomberg  ra pharmaceuticals rarx updates on initial data from phase  clinical trial of ra in pnh  slideshow seeking alpha  lowe wealth advisors llc holds position in verizon communications inc vz emfizzcom  analysts anticipate verizon communications inc vz to announce  eps wp super fanboy  verizon communications inc nysevz stake increased by investment counsel inc healthcaremenunet  ra pharmaceuticals announces publication of positive preclinical data with ra for the treatment of escherichia coli sepsis pipelinereviewcom  global sepsis drug pipeline market research for  insights shared in detailed report whatech  ra pharmaceuticals announces publication of positive preclinical data with ra for the treatment of escherichia coli sepsis wallstreet online  ra pharmaceuticals announces publication of positive preclinical data with ra for the treatment of escherichia coli sepsis tmcnetcom  ra pharmaceuticals announces publication of positive preclinical data with ra for the treatment of escherichia coli sepsis pharmiweb  ra pharmaceuticals announces publication of positive preclinical data with ra for the treatment of escherichia  newsoneplacecom  ra pharmaceuticals announces publication of positive preclinical data with ra for the treatment of escherichia coli sepsis business wire  ra pharmaceuticals  announces publication of positive preclinical data with ra for the treatment of escherichia coli sepsis  traders  ra pharmaceuticals announces publication of positive preclinical data with ra for the treatment of escherichia coli sepsis digital journal  myasthenia gravis pipeline market insights of company and drug profiles h  medgadget  ra pharmaceuticals announces publication of positive preclinical  fox wflx tv west palm beach flnews  weather fox  wflx  cant afford another window to deposit banned notes centre tells supreme court gizpresscom  adchoices adchoices adchoices markets dow dow ▲    last updated time   am edt markets nasdaq nasdaq ▼    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft ra pharmaceuticals inc private company information  bloomberg july    am et biotechnology company overview of ra pharmaceuticals inc snapshot people company overview ra pharmaceuticals inc a clinicalstage biopharmaceutical company discovers and develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system in the united states the company’s peptide chemistry platform enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules its lead product candidate is ra an injection into the tissue under the skin for the treatment of paroxysmal nocturnal hemoglobinuria pnh as well as for the treatment of other debilitating complementmediated diseases including refractory generaliz ra pharmaceuticals inc a clinicalstage biopharmaceutical company discovers and develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system in the united states the company’s peptide chemistry platform enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules its lead product candidate is ra an injection into the tissue under the skin for the treatment of paroxysmal nocturnal hemoglobinuria pnh as well as for the treatment of other debilitating complementmediated diseases including refractory generalized myasthenia gravis rmg and lupus nephritis lp the company’s preclinical testing products include factor d inhibition for agerelated macular degeneration and geographic atrophy as well as for orphan renal dense deposit and c glomerulonephritis oral c inhibitor for pnh rmg ln and central nervous system cns diseases and cs inhibition for autoimmunecns diseases it has multitarget collaboration and license agreement with merck  co inc ra pharmaceuticals inc was founded in  and is based in cambridge massachusetts detailed description  cambridge park drivecambridge ma united statesfounded in  employees phone  fax  wwwrapharmacom key executives for ra pharmaceuticals inc dr douglas a treco phd chief executive officer president cofounder and director age  total annual compensation k mr david c lubner cpa chief financial officer and executive vice president of operations age  total annual compensation k dr ramin farzanehfar md facc chief medical officer age  total annual compensation k dr simon read phd chief scientific officer age  total annual compensation k compensation as of fiscal year  ra pharmaceuticals inc key developments ra pharmaceuticals inc announces publication of positive preclinical data with ra for the treatment of escherichia coli sepsis jul   ra pharmaceuticals inc announced the publication of in vitro and in vivo data demonstrating that treatment of escherichia coli sepsis with ra was associated with significant organ protection and markedly reduced mortality researchers evaluated the effect of ra a macrocyclic peptide inhibitor of complement component  c in baboons receiving lethal doses of e coli as compared with placebo treatment with ra blocked sepsisinduced inflammation preserved endothelial cell function decreased leukocyte activation and reduced overall mortality while exhibiting no detrimental effects on the clearance of bacteria inhibition of c is a clinicallyvalidated approach for the treatment of complementmediated disorders ra pharma’s portfolio includes drug candidates for several such disorders including pnh myasthenia gravis mg and lupus nephritis ln ra pharmaceuticals inc announces encouraging data from phase ii paroxysmal nocturnal hemoglobinuria study jun   ra pharmaceuticals inc has announced encouraging initial data from the companys global phase ii clinical program evaluating ra for the treatment of paroxysmal nocturnal hemoglobinuria pnh ra pharma is developing ra as a novel subcutaneouslyadministered sc inhibitor of complement component  c the dosefinding phase ii clinical program is designed to evaluate the safety tolerability preliminary efficacy pharmacokinetics pk and pharmacodynamics pd of ra in patients with pnh currently the study has three eculizumabnaive patients enrolled of which two have completed seven weeks of followup and are included in the companys initial data set review of these initial data enables the opening of cohort b which will enroll patients switching from eculizumab the current standard of care for pnhnotable findings include no safety or tolerability concerns identified no injection site reactions nearcomplete inhibition of hemolytic activity rapid declines in lactate dehydrogenase ldh mean ldh at week   x upper limit of normal uln and  compliance with once daily subcutaneous selfadministrationat the week  visit one patient reported recurrence of pnh symptoms associated with hemoglobinuria and an elevated ldh level this episode of breakthrough hemolysis occurred in the setting of an intercurrent illness judged by the investigator to be most likely due to a viral infection ra pharmaceuticals announces presentation of data at  european hematology association jun   ra pharmaceuticals inc has announced the presentation of scientific data at the nd congress of the european hematology association eha in madrid spain the data presented at eha showcase a novel class of orally bioavailable small molecules that bind to c with high affinity and inhibit its cleavage into ca and cb these findings demonstrate the feasibility of an orallyadministered therapy for complementmediated disorders and support the continued advancement of these molecules inhibition of c is a clinicallyvalidated approach for the therapeutic treatment of complementmediated disorders ra pharmas portfolio includes drug candidates for several such disorders including paroxysmal nocturnal hemoglobinuria pnh myasthenia gravis mg and lupus nephritis ln the company is pursuing the identification of orallyavailable inhibitors of c with the goal of providing additional options for patients diagnosed with these and other complementmediated disorders similar private companies by industry company name region n labs inc united states andme inc united states c tech corporation inc united states v biosciences inc united states bar biologics inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact ra pharmaceuticals inc please visit wwwrapharmacom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close ra treatment options  xeljanz® tofacitinib citrate  safety info skip to main content home menu menu register for info menu scroll up to unhide the main menu home ra treatments treatments for ra treatments for ra what is xeljanzxeljanz xr xeljanzxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children scroll for important safety information important safety information what is the most important information i should know about xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide   you are now leaving xeljanzcom links to other sites are provided as a convenience to the visitor pfizer accepts no responsibility for the content of linked sites would you like to continue yes no   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm close x copay card terms and conditions by using the xeljanz® xr tofacitinib citrate extended releasexeljanz® tofacitinib citrate instant copay savings card the “card” you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions the card is not valid for prescriptions that are eligible to be reimbursed in whole or in part by medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan available in puerto rico formerly known as “la reforma de salud” the card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription drugs you will receive a maximum benefit of  per calendar year which is defined by the date of enrollment through december st of the enrollment year with a  per month copay after a maximum of  you will be responsible for paying the remaining monthly outofpocket costs the card may be used once per month for the life of the program you must deduct the value received under this program from any reimbursement request submitted to your insurance plan either directly by you or on your behalf cannot be combined with any other rebatecoupon free trial or similar offer for the specified prescription the card will be accepted only at participating pharmacies the card is not health insurance offer good only in the us and puerto rico the card is limited to  per person during this offering period and is not transferable pfizer reserves the right to rescind revoke or amend the program without notice no membership fee card and program expires  if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide close x important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide close x what is xeljanzxeljanz xr xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children continue to site scroll for more information popup prescribing information medication guide close x xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well now available xeljanz is now available as a oncedaily pill called xeljanz xr ask your doctor if xeljanz xr is right for you important safety information and indication what is the most important information i should know about xeljanz® tofacitinib citratexeljanz® xr tofacitinib citrate xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide ppxelusa close x trial rx program terms and conditions this is not health insurance and is a onetimeonly offer for eligible commercially insured patients offer is only available to patients who have been diagnosed with an fdaapproved indication for xeljanz® xr tofacitinib citrate extended release patients who have already begun therapy with xeljanz xr at the time of the request and patients under the age of eighteen  years of age are ineligible for participation in the program no claim for reimbursement for product dispensed pursuant to this offer may be submitted to any thirdparty private payer not available to patients covered under government plans such as medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan or for residents of massachusetts available in a day supply this offer does not require nor will be made contingent on purchase requirements of any kind pfizer reserves the right to amend rescind or discontinue this program at any time without notification trial rx can only be dispensed by the exclusive pharmacy and only after benefits investigation has been completed additional eligibility criteria may apply contact xelsource for details if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide rheumatoid arthritis ra treatment options from pills like methotrexate xeljanz and oncedaily xeljanz xr to infusions and needlebased injections there are many different medications available for treating rheumatoid arthritis ra when talking with your healthcare provider about the right treatment option for you it’s important to remember that ra affects everyone differently including how fast it progresses and you should work with your healthcare team to assess available treatment options a healthcare provider will often prescribe different medications at different times depending on a patient’s unique situation while treatment paths may vary click below to learn more about potential treatment options nsaids for example ibuprofen what are nsaids about nsaids nsaids nonsteroidal antiinflammatory drugs are often prescribed along with dmards to help reduce pain and swelling in the joints while dmards can help reduce the progression of joint damage nsaids only treat pain and inflammation how do nsaids work nsaids block the production of prostaglandins which are involved in triggering inflammation and increasing pain how to take it pill or patch steroids for example prednisone what are steroids about steroids steroids in this case short for corticosteroids  are naturally occurring hormones produced by the adrenal glands above the kidneys during exercise or as a reaction to stress how do steroids work steroids normally help replace energy stores that are used up during exercise or stress and promote efficient operation of the cardiovascular system steroids also reduce the swelling and decrease inflammation associated with ra healthcare providers rarely use or prescribe corticosteroids by themselves and will often use them only when you have acute ra symptoms including inflammation in a single joint how to take it topical ointment pill or an injection into a muscle or directly into an affected joint while nsaids and steroids may be used along with other treatments to help manage pain and swelling a healthcare provider may also recommend methotrexate which unlike nsaids and steroids can help slow the progression of ra joint damage dmards for example methotrexate what are dmards about methotrexate methotrexate is one of the most commonly prescribed dmards diseasemodifying antirheumatic drugs other common dmards include hydroxychloroquine and sulfasalazine methotrexate is often prescribed at the time of diagnosis to help reduce pain and swelling in the joints and the progression of joint damage how does methotrexate work methotrexate interferes with the production and maintenance of dna the genetic material in the cells of your body it is not fully known how methotrexate works to treat ra how to take it pill and in some cases an injection if methotrexate isnt doing enough other treatment options are available to help reduce your ra symptoms jak inhibitors for example xeljanz® tofacitinib citrate what are jak inhibitors about jak inhibitors janus kinase jak inhibitors another type of dmard are the first in a class of treatments for moderate to severe ra xeljanz a jak inhibitor has been shown to help reduce pain and swelling in the joints and to slow the progression of joint damage xeljanz can work alone it is proven to reduce ra pain swelling and joint damage without the need for methotrexate xeljanz is also available as a oncedaily pill called xeljanz xr how do jak inhibitors work jak inhibitors work deep inside the cell to disrupt the signaling pathways between the cells of your immune system that are believed to play a role in the inflammation associated with ra how to take it pill biologics for example humira® adalimumab what are biologics about biologics biologics target the underlying disease process including specific parts of the immune system to help reduce moderate to severe ra symptoms biologics another type of dmard have been shown to help reduce pain swelling and stiffness in the joints and the progression of joint damage how do biologics work there are various types of biologics available each working in different ways to reduce target or block proteins that when your body produces too much of them can play a role in the pain symptoms and joint damage of ra how to take it injection andor infusion depending on medication learn about xeljanz list of ra medications with so many different treatment options sometimes it can be hard to keep track of what’s what or how xeljanz fits into the mix that’s why we’ve put together a list of ra medications and grouped them by the type of treatment and how each medication is given sort by type of treatmenthow to take medication dmard arava® leflunomide methotrexate plaquenil® hydroxychloroquine sulfate sulfasalazine jak inhibitor xeljanz® tofacitinib citrate xeljanz® xr tofacitinib citrate extended release biologic actemra® tocilizumab cimzia® certolizumab pegol enbrel® etanercept humira® adalimumab orencia® abatacept remicade® infliximab rituxan® rituximab simponi® golimumab pill arava® leflunomide methotrexate plaquenil® hydroxychloroquine sulfate sulfasalazine xeljanz® tofacitinib citrate xeljanz® xr tofacitinib citrate extended release injection actemra® tocilizumab cimzia® certolizumab pegol enbrel® etanercept humira® adalimumab methotrexate orencia® abatacept simponi® golimumab infusion actemra® tocilizumab orencia® abatacept remicade® infliximab rituxan® rituximab simponi® aria® golimumab as of april  the brand names included throughout are the properties of their respective owners table is not meant to imply a comparison of product effectiveness what is xeljanz learn more important safety information  indication expand or collapse important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide safety  side effects of xeljanz® tofacitinib citrate  xeljanz xr® tofacitinib citrate skip to main content home menu menu register for info menu scroll up to unhide the main menu home about xeljanz what is xeljanz what is xeljanz what is xeljanzxeljanz xr xeljanzxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children scroll for important safety information important safety information what is the most important information i should know about xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide   you are now leaving xeljanzcom links to other sites are provided as a convenience to the visitor pfizer accepts no responsibility for the content of linked sites would you like to continue yes no   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm close x copay card terms and conditions by using the xeljanz® xr tofacitinib citrate extended releasexeljanz® tofacitinib citrate instant copay savings card the “card” you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions the card is not valid for prescriptions that are eligible to be reimbursed in whole or in part by medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan available in puerto rico formerly known as “la reforma de salud” the card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription drugs you will receive a maximum benefit of  per calendar year which is defined by the date of enrollment through december st of the enrollment year with a  per month copay after a maximum of  you will be responsible for paying the remaining monthly outofpocket costs the card may be used once per month for the life of the program you must deduct the value received under this program from any reimbursement request submitted to your insurance plan either directly by you or on your behalf cannot be combined with any other rebatecoupon free trial or similar offer for the specified prescription the card will be accepted only at participating pharmacies the card is not health insurance offer good only in the us and puerto rico the card is limited to  per person during this offering period and is not transferable pfizer reserves the right to rescind revoke or amend the program without notice no membership fee card and program expires  if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide close x important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide close x what is xeljanzxeljanz xr xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children continue to site scroll for more information popup prescribing information medication guide close x xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well now available xeljanz is now available as a oncedaily pill called xeljanz xr ask your doctor if xeljanz xr is right for you important safety information and indication what is the most important information i should know about xeljanz® tofacitinib citratexeljanz® xr tofacitinib citrate xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide ppxelusa   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no close x trial rx program terms and conditions this is not health insurance and is a onetimeonly offer for eligible commercially insured patients offer is only available to patients who have been diagnosed with an fdaapproved indication for xeljanz® xr tofacitinib citrate extended release patients who have already begun therapy with xeljanz xr at the time of the request and patients under the age of eighteen  years of age are ineligible for participation in the program no claim for reimbursement for product dispensed pursuant to this offer may be submitted to any thirdparty private payer not available to patients covered under government plans such as medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan or for residents of massachusetts available in a day supply this offer does not require nor will be made contingent on purchase requirements of any kind pfizer reserves the right to amend rescind or discontinue this program at any time without notification trial rx can only be dispensed by the exclusive pharmacy and only after benefits investigation has been completed additional eligibility criteria may apply contact xelsource for details if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide quick facts if moderate to severe rheumatoid arthritis ra pain is getting in the way of your normal activities it may be time to ask if xeljanz or the oncedaily formulation xeljanz xr could be right for you vertical tabs  available by prescription xeljanz pronounced zeljans  is a small pill that treats moderate to severe ra xeljanz is also available as a oncedaily pill called xeljanz xr learn more about oncedaily xeljanz xr here   xeljanz is proven to work alone—even without methotrexate  xeljanz is the first in a class of treatments for moderate to severe ra called janus kinase jak inhibitors if methotrexate hasn’t done enough to help relieve your ra symptoms and before you and your rheumatologist decide on a biologic ask if xeljanz is right for you  xrays have shown that xeljanz helps stop further joint damage  in some patients xeljanz began to work in as early as  weeks to reduce ra joint pain and swelling in clinical trials more than half of xeljanz patients felt an improvement in ra symptoms at  months everyone is different your results may vary  xeljanz is a pill proven to reduce ra pain swelling and joint damage—even without methotrexate see alison’s story  the easytoopen xeljanz bottle cap was awarded the arthritis foundation’s easeofuse commendation† †the arthritis foundation’s easeofuse commendation recognizes products such as the xeljanz bottle cap proven to make life easier for people who have arthritis and other physical limitations quick facts if moderate to severe rheumatoid arthritis ra pain is getting in the way of your normal activities it may be time to ask if xeljanz could be right for you a small pill available by prescription xeljanz pronounced zeljans  is a small pill that treats moderate to severe ra xeljanz is also available as a oncedaily pill called xeljanz xr learn more about oncedaily xeljanz xr here   xeljanz is proven to work alone—even without methotrexate a jak inhibitor xeljanz is the first in a class of treatments for moderate to severe ra called janus kinase jak inhibitors if methotrexate hasn’t done enough to help relieve your ra symptoms and before you and your rheumatologist decide on a biologic ask if xeljanz is right for you helps stop further joint damage xrays have shown that xeljanz helps stop further joint damage reduces ra pain and symptoms in some patients xeljanz began to work in as early as  weeks to reduce ra joint pain and swelling in clinical trials more than half of xeljanz patients felt an improvement in ra symptoms at  months everyone is different your results may vary can be taken alone xeljanz is a pill proven to reduce ra pain swelling and joint damage—even without methotrexate see alison’s story easytoopen bottle the easytoopen xeljanz bottle cap was awarded the arthritis foundation’s easeofuse commendation† †the arthritis foundation’s easeofuse commendation recognizes products such as the xeljanz bottle cap proven to make life easier for people who have arthritis and other physical limitations want to know the difference between xeljanz and xeljanz xr learn more here how xeljanz works   close x   xeljanz is a janus kinase jak inhibitor that works deep inside the cell to disrupt activities occurring in signaling pathways these jak pathways are believed to play a role in the inflammation associated with ra watch to learn more about the science of xeljanz and how it works to help disrupt the processes that can lead to inflammation video description take a closer look at how xeljanz works clinical trial results the effectiveness of xeljanz taken with and without a diseasemodifying antirheumatic drug dmard such as methotrexate was tested in six studies that involved more than  adult patients with ra     more than half of xeljanz patients felt an improvement in ra symptoms within  months in the oral solo study at  weeks  of xeljanz patients  out of  and  of placebo patients  out of  experienced a  reduction in tender and swollen joint counts and  of these  indicators blood test that measures inflammation patient assessment physician assessment pain scale and disabilityfunctional questionnaire at  months  of xeljanz patients  out of  and  of placebo patients  out of  experienced the same results during this study patients did not take methotrexate at  months more than half of xeljanz patients could more easily complete daily activities such as getting dressed walking down stairs and gripping household items in the oral solo study a scale was used that defines ra disability as   mild   moderate to severe   greater disability at the study start xeljanz patients had a mean baseline score of  at  months xeljanz patients saw an improved score of  a statistically important difference and overall   out of  of xeljanz patients experienced an improvement ≥ on the health assessment questionnaire disability index haqdi that assesses the following categories dressing and grooming arising eating walking hygiene reach grip and common daily activities during this study patients did not take methotrexate xeljanz reduced joint pain and swelling caused by ra even without the use of methotrexate in the oral solo study at  weeks  of xeljanz patients  out of  and  of placebo patients  out of  experienced a  reduction in tender and swollen joint counts and  of these  indicators blood test that measures inflammation patient assessment physician assessment pain scale and disabilityfunctional questionnaire at  months  of xeljanz patients  out of  and  of placebo patients  out of  experienced the same results during this study patients did not take methotrexate at  months xeljanz patients experienced less joint damage progression than methotrexate patients based on two studies xeljanz was shown on xrays to help reduce further structural joint damage this included holes in the bones known as erosions and the narrowing of the space between the bones where cartilage has been lost in the oral start study xeljanz patients hadnt taken methotrexate prior to the study however xeljanz is only approved for use in patients for whom methotrexate did not work well at  months xeljanz patients got worse by  units of change on the modified total sharp score mtss scale while patients taking methotrexate worsened by  mtss measures joint damage progression in selected joints of the hands and feet the higher the amount of change in the mtss the more joint damage has progressed in the oral scan study patients who took xeljanz and methotrexate had less progression of joint damage after  months  than those who took a placebo and methotrexate  however the possibility was high enough that the difference between treatments may have been due to chance alone and not due to xeljanz so the results were not considered significant     patient testimonial pullquote within  to  weeks i began to notice a difference individual results may vary  alison xeljanz patient watch alison’s story safety  side effects serious infections close x serious infections serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have back next cancer and immune system problems close x cancer and immune system problems cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder back next tears perforation in the stomach or intestines close x tears perforation in the stomach or intestines tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits back next changes in certain lab test results close x changes in certain lab test results changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that back next what should i tell my healthcare provider before taking xeljanzxeljanz xr close x what should i tell my healthcare provider before taking xeljanzxeljanz xr what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these back next what are other possible side effects of xeljanzxeljanz xr close x what are other possible side effects of xeljanzxeljanz xr what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis these are not all of the possible side effects of xeljanzxeljanz xr please see the prescribing information including boxed warning and medication guide for additional information and complete details about xeljanz back next request more info about xeljanz sign up now important safety information  indication expand or collapse important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide ra pharma » jobs home about us management team board of directors scientific advisory board pipeline overview ra preclinical  discovery programs therapeutic areas our science overview extreme diversity™ platform partnership news  investors overview news  events presentations and publications stock information sec filings corporate governance investor faq contact us working at ra our work philosophy open positions   open positions process development engineer drug product job code pdpde ra pharmaceuticals inc nasdaq rarx is a clinical stage biotechnology company focused on development of novel therapeutics for the treatment of serious diseases that are caused by dysregulation of the complement system a critical component of the immune system ra pharma combines its expertise in the area of complement biology with leadership in macrocycle peptide technology to discover and develop therapeutics that transform the lives of patients with life threatening disorders description we are seeking a process engineer experienced in drug product process development and manufacturing to join our pharmaceutical development cmc team the ideal candidate will have a bsc msc or phd in chemical engineering chemistry biochemistry or related field with significant experience developing sterile parenteral drug product manufacturing processes spanning multiple platform technologies and unit operations including sterile filtration ufdf disposable and stainlesssteel technologies tangential flow filtration tff high shear homogenization liposome production spray drying syringe and vial filling etc in addition experience with high viscosity sterile filling operations andor oral dosage form production is highly desireable candidates should have handson experience with the development and execution of fillfinish technical operations and reporting as well as batch record authorship and review equipment procurement and qualification and cgmp’s to allow for effective oversight of third party cmo activities supporting ra pharma needs the successful candidate should be an excellent communicator and extremely well organized experience with design control of medical device combination product is highly desirable responsibilities design lead and execute bench scale process development activities as well as provide oversight to rd party scale up of drug product manufacturing including sterile filtration fillfinish and compounding across a diverse range of sterile product unit operations provide technical review of rd party batch records and related gmp documentation eg raw material specifications equipment specifications validation supportive development protocols  reports effectively communicate with vendors and internal team members and key stakeholders across the cmc team on the status objectives risks and mitigation plans associated with ongoing plans and activities for ensuring a robust and high quality clinical  commercial drug supply work directly with various rd parties to support development qualification supply and cgmp manufacture  packaging  labeling maintain drug product database containing pedigree of all gmp manufacturing and development activities ie raw material lot ’s assay yield deviations and other performance attributes maintain critical quality attribute inprocess and release data tracking and trending analysis as well as inprocess equipment parameter tracking and trending analyses assist in providing ‘man in plant’ oversight to gmp related activities by rd party suppliers lead and assist with all drug product clinical technical transfer efforts to rd party cmos ensure complete and effective investigations ie root cause and capa are conducted and documented to support the quality of drug supply conduct formal risk assessments to support phase  registration and submission help oversee rd party development and qualification activities including extractable  leachables cci autoinjector and sterile filtration assist quality assurance in conducting supplier audits author and support writing the drug product sections of cmc regulatory filings knowledge  skills strong understanding of development of sterile dp processes from development batches through scale up and commercialization experience with clean room personnel  material flows and aseptic processing functional and regulatory requirements experience with drug product compounding biodisposable and stainless steel strategies sterile filtration mixing strategies fluid transfer to and from various compounding vesselsbiobags qc sampling requirements current in cgmps and how to implement process designs and systems that promote cgmp compliance computer literate in excel word visio salary and title commensurate with experience please submit cover letter and resume to hrrapharmacom manager regulatory affairs job code raf  ra pharmaceuticals inc nasdaq rarx is a clinical stage biotechnology company focused on development of novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system a critical component of the immune system ra pharma combines its expertise in area of complement with leadership in macrocycle peptide technology to discover and develop therapeutics that transform the lives of patients with life threatening disorders description ra pharma is seeking an experienced and energetic person to manage evaluate and complete regulatory projects consistent with company goals this individual will be responsible for timely planning and coordination of regulatory submissions and provide guidance to crossfunctional teams on regulatory strategy and tactics the sr specialistmanager will represent regulatory affairs on crossfunctional project teams will provide input to the project team will lead authoring and preparation of annual reporting and will manage regulatory submissions and regulatory archive responsibilities with minimal supervision plan and manage regulatory activities related to assigned projects that span technical areas including clinical nonclinical and cmc assist in developing and implementing strategies for the earliest possible approvalsclearance of regulatory submissions associated with assigned projects manage the preparation including writing as necessary assembly review and timely submission of regulatory dossiers as required for investigation and registration of products in the us and abroad ensure regulatory submissions are maintained in compliance with regulatory requirements support and manage preparation of meeting requests and briefing documents manage the preparation review and submission of all components of regulatory submissions including inds and amendments blasndas and supplements annual reports safety reports etc participate on project teams and provide expertise on regulatory matters develop and maintain current regulatory knowledge and advise management of significant developments prepare and maintain regulatory archive work with external regulatory consultantscro’s as required qualifications the ideal candidate should have a minimum of  years overall regulatory experience in the pharmaceutical industry the candidate must have a babs degree or equivalent in a health science field experience and knowledge in preparation of inds and ndas desirable and supportive amendments and supplements manufacturing nonclinical clinical experience with ctdectd experience with publishing documents in adobe acrobat professional working knowledge of fda and ich regulatory guidance and regulations understanding of fda structure and function knowledgeexperience with regulatory requirements for other regions also desirable working knowledge of gmp glp and gcp regulations as well an understanding of the pharmaceutical product life cycle excellent oral and written communication skills are a must as are superior planning skills the candidate should be detailoriented a selfstarter and be comfortable with broad responsibilities in an entrepreneurial fastpaced small company environment salary and title commensurate with experience please submit cover letter and resume to hrrapharmacom process development chemist or engineer job code cmcpc ra pharmaceuticals inc nasdaq rarx is a clinical stage biotechnology company focused on development of novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system a critical component of the immune system ra pharma combines its expertise in area of complement with leadership in macrocycle peptide technology to discover and develop therapeutics that transform the lives of patients with life threatening disorders description we are seeking an experienced chemist or engineer to join our pharmaceuticals development team and contribute to the preclinical and early phase development of peptide peptidomimetic and small molecule drugs the ideal candidate will have a bsc msc or phd in chemistry or chemical engineering or related field with significant solidphase peptide synthesis and synthetic process development experience candidates should have handson experience with manual and automated solidphase peptide synthesis and standard techniques in small molecule synthesis additionally candidates should have experience with preparative and analytical hplc as well as deep knowledge of key characterization techniques for peptide and small molecule drugs experience with cgmp processes and with cmc regulatory filings is preferred the successful candidate should be a natural leader with excellent communication skills and the ability to work in teams and across disciplines responsibilities in house scale up of discovery lead compounds for support of preclinical and preformulation investigations establishing initial scalable synthetic and purification processes for peptide peptidomimetic and small molecule drug candidate manufacture either internally or with cmo partners in support of preclinical and early phase studies solidphase peptide synthetic and purification process development to make scalable reproducible and transferable processes for use in cmo manufacture of clinical phase materials communication with cmos and preparation of technical transfer documents in consultation with other internal pharma development team members prepare technical development protocols and reports writing and support of drug substance sections of cmc regulatory filings maintain instrumentation and laboratory process instrumentation and equipment serve as a representative of cmcpharmaceutical development group on project teams and help drive preclinical and early phase cmc activities salary and title commensurate with experience please submit cover letter and resume to hrrapharmacom sr dirdirassociate dir cmc program management job code cmcpm  ra pharmaceuticals is looking to strengthen its pharmaceutical development team with the addition of a cmc program manager ra is a growing biotech company headquartered in cambridge boston focused on novel therapeutics for rare diseases ra employs both macrocyclic peptides and traditional small molecules to address dysfunction of the complement cascade the pipeline at ra pharmaceuticals encompasses ra a macrocyclic peptide inhibitor of c currently entering phase ii an extended release version of ra factor d inhibitors for rare systemic renal disorders and dry amd as well as two projects in lead identification  lead optimization c inhibitor and c oral small molecule as the pipeline matures we are looking to strengthen our pharmaceutical development group by recruiting key leadership and providing project management we are currently recruiting for a motivated individual to join the team and lead cmc project management the ideal candidate is expected to have a strong project management expertise be able to lead through influence and motivate teams and external vendors to keep on task the cmc program manager will work closely with cmc teams a diverse network of vendors and program teams to ensure achievement of deliverables communication of project goals and expectations as well as help drive decision making identify resource limitations help minimize impact on timelines and maintain the development budget responsibilities serve as an integral cmc team member across multiple development projects to achieve development manufacturing and project goals work collaboratively with cmc functions early development analytical development drug substance development drug product development supply chain quality control quality assurance and regulatory to ensure strong clear communication to identify avoid or address issues in pharmaceutical development and manufacturing effectively communicate with team members senior leaders and key stakeholders on the status objectives risks and mitigation plans associated with the various cmc projects as well as ensure cmc teams are aware of current integrated program timelines work with vendor network to maintain relations to address conflicts in thoughtful and productive manner negotiate work plans and timelines ensure deliverables are met develop and maintain detailed and integrated cmc project plans to identifycommunicate project interdependencies as well as critical path activities across multiple development programs provides expertise and strategic guidance to multifunctional project teams as a pharmaceutical development representative track project tasks and efforts associated with pharmaceutical development cmc manufacturing quality and supply chain interact with clinical teams to project drug needs presentation and timing work with ds and dp department heads as well as an outsourced clinical supply management to manage manufacturing scheduling and logistics facilitate cmc team meetings to drive crossfunctional communication timely and effective decision making and successful execution of cmc objectives help foster a team culture of scientific curiosity high productivity ownership and accountability requirements and job qualifications the successful candidate will be a confident leader with significant experience and success in project management have a strong desire to apply project management skills to deliver novel medicines to improve patients’ lives and an understanding of cmc drug development strategies practices and regulatory agency expectations s msphd in pharmacology chemistry biochemistry or a related discipline minimum of  years of pharmaceuticalbiotechnology project management experience minimum of  year’s handson expertise in drug development as well as managing research performed at external cros experience with late stage development highly desirable experience with ind nda impd and maa filings is desirable excellent writing and language skills along with strong communication and team management skills the ability to adapt to a fastpaced environment and meet aggressive timelines exceptional organizational and interpersonal skills as well as an ability to drive results through influencing others are a must strong detail orientation and driven to achieve a strong knowledge of program budget processes to apply please send your résumécv and cover letter to hrrapharmacom head of preclinical development job code hpd ra pharmaceuticals is a growing biotech company headquartered in cambridge massachusetts ra is focused on novel therapeutics for dysfunction of the complement cascade in rare diseases the company was founded on a macrocyclic peptide platform although the pipeline has matured to include both macrocycles and traditional small molecule approaches to inhibition of the complement cascade ra pharmaceuticals has successfully delivered its most mature project ra a macrocyclic peptide inhibitor of c into phase ii and completed a successful ipo in october  the emerging pipeline consists of several projects reaching candidate selection in  factor d for rare systemic renal disorders andor dry amd an extended release version of ra as well as two projects in lead identification  lead optimization c inhibitor and oral small molecule c inhibitor projects as our pipeline matures we are looking to strengthen our preclinical development group by recruiting key leadership and consolidating the functions of safetytoxicology and dmpk therefore we are currently recruiting for a head of preclinical development with salary and title commensurate with experience the ideal candidate is expected to have a strong core understanding of toxicology immunotoxicity adme and pharmacokinetics derived from either direct line leadership of one or several of these functions or significant experience in leading projects into clinical development as a senior member of the rd leadership team this position will be expected to be a key contributor to developing ra’s pipeline as such this individual will work seamlessly from research into clinical development working closely with clinical functions and regulatory responsibilities build and lead a preclinical development team to head count target of  ftes in  thereafter assess portfolio needs and requirement for further additional fte  lead toxicology and dmpk to oversee all nonclinical studies required for regulatory filings clinical stage testing and product approval oversight of indenabling pkpd modeling and simulation leadership of the stageappropriate development and implementation of bioassays for preclinical and clinical studies as a member of the rd leadership team provide oversight and guidance to all rd activities in the company and ongoing input to the executive leadership team provide strategic and handson management ensuring that toxicology studies are conducted in line with the appropriate regulatory guidelines and standards fda who glp and iso oversight of preclinical development budget initiate and manage contracts in conjunction with finance group coordinates activities with select contract research organizations cros and academic collaborators for preclinical development in the areas of toxicology pharmacology pharmacokinetics prepare reports regulatory documents and inds work closely with other functional areas and colleagues to ensure all studies are performed in a quality timely and scientific manner provide preclinical expertise and strategy to multifunctional project teams as the preclinical representative ensure compliance with gcp gmp and regulatory guidelines as appropriate requirements and qualifications the successful candidate will be a confident leader with rigorous scientific intellect and standards the successful candidate will have significant prior success in building and leading preclinical research organizations and developing novel medicines that progress through development ideally to approval and commercialization and possessing the following qualifications d in pharmacology physiology or related discipline minimum of  years of pharmaceuticalbiotechnology industry experience minimum of  year’s handson expertise developing and managing preclinical studies including those performed at external cros mastery of preclinical drug development strategies practices and fda regulations experience with biologics and related immunological studies required demonstrated proficiency in nonclinical study design and management demonstrated results in preclinical development and a track record of successful ind nda and bla filings previous experience and success with choosing and managing relations with external contractors including cros experience interacting with us and european regulatory authorities experience with all phases of clinical development including preind through phase iv programs and associated regulatory filings excellent writing and language skills along with strong communication and team management skills the ability to adapt to a fastpaced environment and meet aggressive timelines strong leadership and interpersonal skills the individual should have a track record of developing teams and participating in developing culture and people across an organization to apply please send your résumé and cover letter to hrrapharmacom head of formulation job code fd  company description ra pharmaceuticals nasdaq rarx a clinicalstage biopharmaceutical company based in cambridge ma is focused on the discovery development and commercialization of novel therapeutics based on its proprietary peptide chemistry platform ra is developing therapeutics to treat serious diseases that are caused by excessive or uncontrolled activation of the complement system a critical component of the immune system ra pharmaceuticals is assembling a team of highly motivated and experienced professionals who are committed to improving the lives of patients and building a world class biotechnology company position description ra is currently looking for a head of formulation to lead the formulation development efforts for our preclinical and clinical drug development programs this role will be responsible for parenteral formulation development as well as oral small molecule and peptide formulation development responsibilities also include dosage form preparation for preclinical studies the formulation development leader will draw upon sound scientific principles to direct formulation development activities while also demonstrating the organizational skills necessary for documenting activities and clearly presenting data study findings and rationale for the development path forward this function works closely with ra cross functional groups as well as external service providers including process development and drug product gmp manufacturing working collaboratively with other scientists and disciplines pharmacology chemistry pharmaceutical development toxicology and clinical this role will develop formulations and establish a robust drug product stability profile   this individual will work across multiple project teams and be a central formulation resource in the company experience with the following is highly desirable parenteral dosage form development subcutaneous formulating highly lipophilic andor lipid molecules authoring formulation relevant regulatory filing sections process development and processtechnology transfer working with contract researchmanufacturing organizations forced degradation and stability studies requirements a ms or phd degree in chemistry or a closely related subject at least  years of pharmaceutical development experience with focus on drug product development demonstrated ability and direct handson experience with developing parenteral formulations experience with developing subcutaneous sustained release formulations is highly desirable successful development of formulations for clinical evaluation late stage formulation development highly desirable demonstrated ability and direct handson experience with developing highly lipophilic small molecule formulations experience with liquid fill capsules such as soft gelatin capsules is highly desirable experience with glpgmp requirements during clinical development and registration excellent organizational writing communication and negotiation skills with a proven track record of being selfdirected while managing multiple projects proven ability to work in a crossfunctional matrixed and collaborative environment proven ability to effectively manage external manufacturing organizations  collaborators ability to thrive and develop in a biotechnology culture execute studies and research with a sense of urgency with ability to adhere to strategic program objectives while also operatingdirecting handson rd activities please resume and cover letter to hrrapharmacom formulation development research associate job code fdra  company description ra pharmaceuticals nasdaq rarx a clinicalstage biopharmaceutical company based in cambridge ma is focused on the discovery development and commercialization of novel therapeutics based on its proprietary peptide chemistry platform ra is developing therapeutics to treat serious diseases that are caused by excessive or uncontrolled activation of the complement system a critical component of the immune system ra pharmaceuticals is assembling a team of highly motivated and experienced professionals who are committed to improving the lives of patients and building a world class biotechnology company position description we are currently looking for a formulation development research associate to assist the formulation development efforts for our clinical and preclinical drug development programs working closely with the formulation development group leader the successful candidate will assist in the development of pharmaceutical products by performing preformulation and formulation screening experiments as well as preparing materials for preclinical studies under general supervision the candidate will work collaboratively with other scientists and disciplines pharmacology chemistry pharmaceutical development toxicology and clinical operations to develop and prepare drug product test formulations for preclinical evaluation you will be expected to have excellent documentation skills and be able to summarize all activities and data to allow for experimental reproducibility and communicating the supporting rationale most importantly the successful candidate will be selfmotivated capable of working independently and creatively under general supervision able to follow instructions generate data that can be traceable and substantiated and assist with writing reports and data summaries as needed the candidate may assist other departmentsdisciplines such as analytical development with method development sample prep analysis etc additionally the candidate may support in drug product process development studies process optimization scale up and tech transfer to rd party cmo’s job responsibilities under minimal supervision follows methods for the production and testing of new subcutaneous and oral formulations technologies and products assists with new product scaleup process optimization technology transfer and process validation activities generates data to support the development of manufacturing procedures and product specifications write review and edit technical documents maintains an accurate timely and glp compliant laboratory notebook participate in and contribute at team meetings requirements bsms in pharmaceutics biochemistry chemistry or a related discipline and up to  years of experience in a research development or manufacturing environment working with formulation or analytical development experience with general laboratory procedures such as buffer preparation reagent preparation as well as good documentation skills aseptic technique desirable motivated and able to work with minimal supervision able to solve technical problems with enthusiasm in a team environment able to function with general instructions on routine work detailed instructions on new assignments good written and oral communication skills ability to thrive and develop in a biotechnology culture execute studies and research with a sense of urgency and attention to detail please send resume and cover letter to hrrapharmacom ra pharmaceuticals inc  cambridge park drive cambridge ma  google maps phone   inforapharmacom home about us management team board of directors scientific advisory board pipeline overview ra preclinical  discovery programs factor d inhibitor oral c inhibitor cs inhibitor therapeutic areas paroxysmal nocturnal hemoglobinuria pnh refractory generalized myasthenia gravis rmg lupus nephritis ln our science overview extreme diversity™ platform partnership news  investors overview news  events presentations and publications stock information sec filings corporate governance investor faq contact us working at ra our work philosophy open positions contact  ra pharmaceuticals inc all rights reserved • terms  conditions ra treatment options  xeljanz® tofacitinib citrate  safety info skip to main content home menu menu register for info menu scroll up to unhide the main menu home ra treatments treatments for ra treatments for ra what is xeljanzxeljanz xr xeljanzxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children scroll for important safety information important safety information what is the most important information i should know about xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide   you are now leaving xeljanzcom links to other sites are provided as a convenience to the visitor pfizer accepts no responsibility for the content of linked sites would you like to continue yes no   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm close x copay card terms and conditions by using the xeljanz® xr tofacitinib citrate extended releasexeljanz® tofacitinib citrate instant copay savings card the “card” you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions the card is not valid for prescriptions that are eligible to be reimbursed in whole or in part by medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan available in puerto rico formerly known as “la reforma de salud” the card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription drugs you will receive a maximum benefit of  per calendar year which is defined by the date of enrollment through december st of the enrollment year with a  per month copay after a maximum of  you will be responsible for paying the remaining monthly outofpocket costs the card may be used once per month for the life of the program you must deduct the value received under this program from any reimbursement request submitted to your insurance plan either directly by you or on your behalf cannot be combined with any other rebatecoupon free trial or similar offer for the specified prescription the card will be accepted only at participating pharmacies the card is not health insurance offer good only in the us and puerto rico the card is limited to  per person during this offering period and is not transferable pfizer reserves the right to rescind revoke or amend the program without notice no membership fee card and program expires  if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide close x important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide close x what is xeljanzxeljanz xr xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children continue to site scroll for more information popup prescribing information medication guide close x xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well now available xeljanz is now available as a oncedaily pill called xeljanz xr ask your doctor if xeljanz xr is right for you important safety information and indication what is the most important information i should know about xeljanz® tofacitinib citratexeljanz® xr tofacitinib citrate xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide ppxelusa close x trial rx program terms and conditions this is not health insurance and is a onetimeonly offer for eligible commercially insured patients offer is only available to patients who have been diagnosed with an fdaapproved indication for xeljanz® xr tofacitinib citrate extended release patients who have already begun therapy with xeljanz xr at the time of the request and patients under the age of eighteen  years of age are ineligible for participation in the program no claim for reimbursement for product dispensed pursuant to this offer may be submitted to any thirdparty private payer not available to patients covered under government plans such as medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan or for residents of massachusetts available in a day supply this offer does not require nor will be made contingent on purchase requirements of any kind pfizer reserves the right to amend rescind or discontinue this program at any time without notification trial rx can only be dispensed by the exclusive pharmacy and only after benefits investigation has been completed additional eligibility criteria may apply contact xelsource for details if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide rheumatoid arthritis ra treatment options from pills like methotrexate xeljanz and oncedaily xeljanz xr to infusions and needlebased injections there are many different medications available for treating rheumatoid arthritis ra when talking with your healthcare provider about the right treatment option for you it’s important to remember that ra affects everyone differently including how fast it progresses and you should work with your healthcare team to assess available treatment options a healthcare provider will often prescribe different medications at different times depending on a patient’s unique situation while treatment paths may vary click below to learn more about potential treatment options nsaids for example ibuprofen what are nsaids about nsaids nsaids nonsteroidal antiinflammatory drugs are often prescribed along with dmards to help reduce pain and swelling in the joints while dmards can help reduce the progression of joint damage nsaids only treat pain and inflammation how do nsaids work nsaids block the production of prostaglandins which are involved in triggering inflammation and increasing pain how to take it pill or patch steroids for example prednisone what are steroids about steroids steroids in this case short for corticosteroids  are naturally occurring hormones produced by the adrenal glands above the kidneys during exercise or as a reaction to stress how do steroids work steroids normally help replace energy stores that are used up during exercise or stress and promote efficient operation of the cardiovascular system steroids also reduce the swelling and decrease inflammation associated with ra healthcare providers rarely use or prescribe corticosteroids by themselves and will often use them only when you have acute ra symptoms including inflammation in a single joint how to take it topical ointment pill or an injection into a muscle or directly into an affected joint while nsaids and steroids may be used along with other treatments to help manage pain and swelling a healthcare provider may also recommend methotrexate which unlike nsaids and steroids can help slow the progression of ra joint damage dmards for example methotrexate what are dmards about methotrexate methotrexate is one of the most commonly prescribed dmards diseasemodifying antirheumatic drugs other common dmards include hydroxychloroquine and sulfasalazine methotrexate is often prescribed at the time of diagnosis to help reduce pain and swelling in the joints and the progression of joint damage how does methotrexate work methotrexate interferes with the production and maintenance of dna the genetic material in the cells of your body it is not fully known how methotrexate works to treat ra how to take it pill and in some cases an injection if methotrexate isnt doing enough other treatment options are available to help reduce your ra symptoms jak inhibitors for example xeljanz® tofacitinib citrate what are jak inhibitors about jak inhibitors janus kinase jak inhibitors another type of dmard are the first in a class of treatments for moderate to severe ra xeljanz a jak inhibitor has been shown to help reduce pain and swelling in the joints and to slow the progression of joint damage xeljanz can work alone it is proven to reduce ra pain swelling and joint damage without the need for methotrexate xeljanz is also available as a oncedaily pill called xeljanz xr how do jak inhibitors work jak inhibitors work deep inside the cell to disrupt the signaling pathways between the cells of your immune system that are believed to play a role in the inflammation associated with ra how to take it pill biologics for example humira® adalimumab what are biologics about biologics biologics target the underlying disease process including specific parts of the immune system to help reduce moderate to severe ra symptoms biologics another type of dmard have been shown to help reduce pain swelling and stiffness in the joints and the progression of joint damage how do biologics work there are various types of biologics available each working in different ways to reduce target or block proteins that when your body produces too much of them can play a role in the pain symptoms and joint damage of ra how to take it injection andor infusion depending on medication learn about xeljanz list of ra medications with so many different treatment options sometimes it can be hard to keep track of what’s what or how xeljanz fits into the mix that’s why we’ve put together a list of ra medications and grouped them by the type of treatment and how each medication is given sort by type of treatmenthow to take medication dmard arava® leflunomide methotrexate plaquenil® hydroxychloroquine sulfate sulfasalazine jak inhibitor xeljanz® tofacitinib citrate xeljanz® xr tofacitinib citrate extended release biologic actemra® tocilizumab cimzia® certolizumab pegol enbrel® etanercept humira® adalimumab orencia® abatacept remicade® infliximab rituxan® rituximab simponi® golimumab pill arava® leflunomide methotrexate plaquenil® hydroxychloroquine sulfate sulfasalazine xeljanz® tofacitinib citrate xeljanz® xr tofacitinib citrate extended release injection actemra® tocilizumab cimzia® certolizumab pegol enbrel® etanercept humira® adalimumab methotrexate orencia® abatacept simponi® golimumab infusion actemra® tocilizumab orencia® abatacept remicade® infliximab rituxan® rituximab simponi® aria® golimumab as of april  the brand names included throughout are the properties of their respective owners table is not meant to imply a comparison of product effectiveness what is xeljanz learn more important safety information  indication expand or collapse important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one rarx stock price  ra pharmaceuticals inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us employment costs up  in second quarter bulletin us economicgrowth rate picks up secondquarter gdp  bulletin us europe asia fx rates futures range d d m m m y y djia f    sp f    nasdaq f    gold    silver    crude oil    sp  movers adp  tsco  vz  orly  ca  jci  ffiv  xl  latest newsall times eastern a us gdp accelerates to  in second quarter a chevrons stock slips  premarket after q results a mcconnell blames democrats after healthcare loss  house approves borderwall money a chevron q revenue  bln vs  bln a year ago factset consensus  bln a chevron q factset eps consensus  cents a chevron q eps includes charges of  mln and gains from asset sales of  mln a year treasury yield down by  basis point to  a nasdaq futures down  at  a dow futures off  at  a sp  futures down  at  to be replaced home investing quotes stocks united states rarx overview compare quotes stock screener earnings calendar sectors nasdaq rarx us nasdaq join td ameritrade find a broker ra pharmaceuticals inc watchlist createrarxalert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps na yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd  recent news marketwatch other dow jones ra phamaceuticals started at buy with suntrust rh nov   at  am et by tomi kilgore no headlines available recent news other news press releases ra pharmaceuticals rarx updates on initial data from phase  clinical trial of ra in pnh  slideshow ra pharmaceuticals rarx updates on initial data from phase  clinical trial of ra in pnh  slideshow jun   at  pm et on seeking alpha unshakeable alexion sees off ra and akari unshakeable alexion sees off ra and akari jun   at  am et on seeking alpha ra pharma selloff a buying opportunity  jefferies shares down  ra pharma selloff a buying opportunity  jefferies shares down  jun   at  pm et on seeking alpha ra pharma initial report of midstage results for lead candidate ra in pnh based on two patients another relapsed shares down  ra pharma initial report of midstage results for lead candidate ra in pnh based on two patients another relapsed shares down  jun   at  am et on seeking alpha ra pharma to host conference call june  to discuss midstage results for pnh candidate ra ra pharma to host conference call june  to discuss midstage results for pnh candidate ra jun   at  pm et on seeking alpha q ra pharmaceuticals inc q ra pharmaceuticals inc may   at  pm et on edgar online  edg  q k midstage study underway assessing ra pharmas ra for pnh apr   at  am et on seeking alpha ra pharmaceuticals rarx presents at cowen and company th annual health care conference mar   at  pm et on seeking alpha k ra pharmaceuticals inc mar   at  pm et on edgar online  edg  q k alexion weighing the pros and cons feb   at  pm et on seeking alpha jefferies says familiar names will be the strongest biotechs this year jan   at  pm et on seeking alpha hottest manufacturing stocks now – watt cvi albo ndrm dec   at  pm et on investorplacecom biggest movers in manufacturing stocks now – ons clvs afmd belfb dec   at  pm et on investorplacecom q ra pharmaceuticals inc nov   at  pm et on edgar online  edg  q k bmo likes ra pharma sets  price target nov   at  am et on seeking alpha insiderinsightscom daily round up  nuvasive skechers new mountain finance altisource portfolio solutions nov   at  pm et on seeking alpha insiderinsightscom daily round up  mercer international malvern bancorp nov   at  am et on seeking alpha ipo preview ra pharmaceuticals oct   at  pm et on seeking alpha ra pharmaceuticals ipo should wait for further results oct   at  pm et on seeking alpha ra pharmaceuticals on deck for ipo oct   at  pm et on seeking alpha ra pharmaceuticals announces publication of positive preclinical data with ra for the treatment of escherichia coli sepsis ra pharmaceuticals announces publication of positive preclinical data with ra for the treatment of escherichia coli sepsis jul   at  pm et on businesswire  bzx ra pharmaceuticals announces initial data from phase  clinical trial of ra in pnh ra pharmaceuticals announces initial data from phase  clinical trial of ra in pnh jun   at  am et on businesswire  bzx ra pharmaceuticals presents data on oral small molecule complement inhibitors at the nd congress of the european hematology association ra pharmaceuticals presents data on oral small molecule complement inhibitors at the nd congress of the european hematology association jun   at  am et on businesswire  bzx ra pharmaceuticals to host conference call on initial phase  data for ra in pnh ra pharmaceuticals to host conference call on initial phase  data for ra in pnh jun   at  pm et on businesswire  bzx ra pharmaceuticals to present at the jefferies  global healthcare conference ra pharmaceuticals to present at the jefferies  global healthcare conference may   at  am et on businesswire  bzx ra pharmaceuticals to present at the nd congress of the european hematology association ra pharmaceuticals to present at the nd congress of the european hematology association may   at  am et on businesswire  bzx ra pharmaceuticals to present at the ubs  global healthcare conference ra pharmaceuticals to present at the ubs  global healthcare conference may   at  am et on businesswire  bzx ra pharmaceuticals reports first quarter  financial results and provides corporate update ra pharmaceuticals reports first quarter  financial results and provides corporate update may   at  pm et on businesswire  bzx ra pharmaceuticals initiates dosing of ra in pnh patients apr   at  am et on businesswire  bzx ra pharmaceuticals reports fourth quarter and full year  financial results and provides corporate update mar   at  pm et on businesswire  bzx ra pharmaceuticals to present at the cowen and company th annual health care conference mar   at  am et on businesswire  bzx ra pharma supports th annual rare disease day® and joins global movement to raise awareness for rare diseases feb   at  am et on businesswire  bzx ra pharmaceuticals to present overview of ra and oral c inhibitor at the international pnh interest group annual scientific assembly nov   at  am et on businesswire  bzx ra pharmaceuticals reports third quarter  financial results and provides corporate update nov   at  pm et on businesswire  bzx ra pharmaceuticals receives orphan drug designation in the european union for ra for treatment of paroxysmal nocturnal hemoglobinuria nov   at  am et on businesswire  bzx nasdaq welcomes ra pharmaceuticals inc nasdaq rarx to the nasdaq stock market oct   at  pm et on globenewswire ra pharmaceuticals inc nasdaq rarx to ring the nasdaq stock market opening bell in celebration of ipo oct   at  am et on globenewswire ra pharmaceuticals announces pricing of initial public offering oct   at  am et on businesswire  bzx ra pharmaceuticals inc ra pharmaceuticals inc is a clinical stage biopharmaceutical company it provides pharmaceutical products for treatment of diseases of complement dysregulation it utilizes small molecules and peptide to address pathological targets in the complement cascade it develops a portfolio of drugs and partnerships focused on intracellular proteinprotein interactions and other innovative approaches for addressing unmet medical needs the company was founded by doug a treco and james w broderick in  and is headquartered in cambridge ma see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top initiations nov   at  am et on benzingacom bmo sets outperform rating  target on ra pharmaceuticals nov   at  am et on benzingacom competitors name chg  market cap omeros corp  m ohr pharmaceutical inc  m oncomed pharmaceuticals inc  m omni bio pharmaceutical inc  m competitor data provided by partner content trending tickers powered by amzn  sbux  aapl  xom  x  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience ra pharmaceuticals inc company profile  bloomberg feedback ra pharmaceuticals inc public company company profile sector health care industry biotech  pharma subindustry specialty pharma ra pharmaceuticals inc operates as a clinicalstage biopharmaceutical company the company offers drugs for the treatment of cancer inflammation and autoimmune disease diabetes and cardiovascular ra pharmaceuticals conducts its business in the united states corporate information address  cambridge park drive cambridge ma  united states phone  fax  web url wwwrapharmacom board members chairman company edward mathers new enterprise associates inc presidentceocofounder company douglas treco ra pharmaceuticals inc board members company timothy pearson tesaro inc jason lettmann morgenthaler ventures rajeev shah ra capital management llc show more from the web press releases ra pharmaceuticals announces publication of positive preclinical data with ra for the treatment of escherichia coli jul   nightstar appoints david lubner to its board of directors jul   ra pharmaceuticals announces initial data from phase  clinical trial of ra in pnh jun   ra pharmaceuticals presents data on oral small molecule complement inhibitors at the nd congress of the european hematology jun   ra pharmaceuticals to host conference call on initial phase  data for ra in pnh jun   schizophrenia pipeline therapeutics development drug profiles and key players market analysis report now available at may   ra pharmaceuticals to present at the jefferies  global healthcare conference may   ra pharmaceuticals to present at the nd congress of the european hematology association may   key executives douglas a treco doug presidentceocofounder simon read chief scientific officer ramin farzanehfar chief medical officer alonso ricardo senior vpresearch  development david c lubner exec vpoperationscfo jennifer robinson senior dircomm  investor relations sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data safety  side effects of xeljanz® tofacitinib citrate  xeljanz xr® tofacitinib citrate skip to main content home menu menu register for info menu scroll up to unhide the main menu home about xeljanz what is xeljanz what is xeljanz what is xeljanzxeljanz xr xeljanzxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children scroll for important safety information important safety information what is the most important information i should know about xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide   you are now leaving xeljanzcom links to other sites are provided as a convenience to the visitor pfizer accepts no responsibility for the content of linked sites would you like to continue yes no   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm close x copay card terms and conditions by using the xeljanz® xr tofacitinib citrate extended releasexeljanz® tofacitinib citrate instant copay savings card the “card” you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions the card is not valid for prescriptions that are eligible to be reimbursed in whole or in part by medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan available in puerto rico formerly known as “la reforma de salud” the card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription drugs you will receive a maximum benefit of  per calendar year which is defined by the date of enrollment through december st of the enrollment year with a  per month copay after a maximum of  you will be responsible for paying the remaining monthly outofpocket costs the card may be used once per month for the life of the program you must deduct the value received under this program from any reimbursement request submitted to your insurance plan either directly by you or on your behalf cannot be combined with any other rebatecoupon free trial or similar offer for the specified prescription the card will be accepted only at participating pharmacies the card is not health insurance offer good only in the us and puerto rico the card is limited to  per person during this offering period and is not transferable pfizer reserves the right to rescind revoke or amend the program without notice no membership fee card and program expires  if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide close x important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide close x what is xeljanzxeljanz xr xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children continue to site scroll for more information popup prescribing information medication guide close x xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well now available xeljanz is now available as a oncedaily pill called xeljanz xr ask your doctor if xeljanz xr is right for you important safety information and indication what is the most important information i should know about xeljanz® tofacitinib citratexeljanz® xr tofacitinib citrate xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide ppxelusa   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no close x trial rx program terms and conditions this is not health insurance and is a onetimeonly offer for eligible commercially insured patients offer is only available to patients who have been diagnosed with an fdaapproved indication for xeljanz® xr tofacitinib citrate extended release patients who have already begun therapy with xeljanz xr at the time of the request and patients under the age of eighteen  years of age are ineligible for participation in the program no claim for reimbursement for product dispensed pursuant to this offer may be submitted to any thirdparty private payer not available to patients covered under government plans such as medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan or for residents of massachusetts available in a day supply this offer does not require nor will be made contingent on purchase requirements of any kind pfizer reserves the right to amend rescind or discontinue this program at any time without notification trial rx can only be dispensed by the exclusive pharmacy and only after benefits investigation has been completed additional eligibility criteria may apply contact xelsource for details if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide quick facts if moderate to severe rheumatoid arthritis ra pain is getting in the way of your normal activities it may be time to ask if xeljanz or the oncedaily formulation xeljanz xr could be right for you vertical tabs  available by prescription xeljanz pronounced zeljans  is a small pill that treats moderate to severe ra xeljanz is also available as a oncedaily pill called xeljanz xr learn more about oncedaily xeljanz xr here   xeljanz is proven to work alone—even without methotrexate  xeljanz is the first in a class of treatments for moderate to severe ra called janus kinase jak inhibitors if methotrexate hasn’t done enough to help relieve your ra symptoms and before you and your rheumatologist decide on a biologic ask if xeljanz is right for you  xrays have shown that xeljanz helps stop further joint damage  in some patients xeljanz began to work in as early as  weeks to reduce ra joint pain and swelling in clinical trials more than half of xeljanz patients felt an improvement in ra symptoms at  months everyone is different your results may vary  xeljanz is a pill proven to reduce ra pain swelling and joint damage—even without methotrexate see alison’s story  the easytoopen xeljanz bottle cap was awarded the arthritis foundation’s easeofuse commendation† †the arthritis foundation’s easeofuse commendation recognizes products such as the xeljanz bottle cap proven to make life easier for people who have arthritis and other physical limitations quick facts if moderate to severe rheumatoid arthritis ra pain is getting in the way of your normal activities it may be time to ask if xeljanz could be right for you a small pill available by prescription xeljanz pronounced zeljans  is a small pill that treats moderate to severe ra xeljanz is also available as a oncedaily pill called xeljanz xr learn more about oncedaily xeljanz xr here   xeljanz is proven to work alone—even without methotrexate a jak inhibitor xeljanz is the first in a class of treatments for moderate to severe ra called janus kinase jak inhibitors if methotrexate hasn’t done enough to help relieve your ra symptoms and before you and your rheumatologist decide on a biologic ask if xeljanz is right for you helps stop further joint damage xrays have shown that xeljanz helps stop further joint damage reduces ra pain and symptoms in some patients xeljanz began to work in as early as  weeks to reduce ra joint pain and swelling in clinical trials more than half of xeljanz patients felt an improvement in ra symptoms at  months everyone is different your results may vary can be taken alone xeljanz is a pill proven to reduce ra pain swelling and joint damage—even without methotrexate see alison’s story easytoopen bottle the easytoopen xeljanz bottle cap was awarded the arthritis foundation’s easeofuse commendation† †the arthritis foundation’s easeofuse commendation recognizes products such as the xeljanz bottle cap proven to make life easier for people who have arthritis and other physical limitations want to know the difference between xeljanz and xeljanz xr learn more here how xeljanz works   close x   xeljanz is a janus kinase jak inhibitor that works deep inside the cell to disrupt activities occurring in signaling pathways these jak pathways are believed to play a role in the inflammation associated with ra watch to learn more about the science of xeljanz and how it works to help disrupt the processes that can lead to inflammation video description take a closer look at how xeljanz works clinical trial results the effectiveness of xeljanz taken with and without a diseasemodifying antirheumatic drug dmard such as methotrexate was tested in six studies that involved more than  adult patients with ra     more than half of xeljanz patients felt an improvement in ra symptoms within  months in the oral solo study at  weeks  of xeljanz patients  out of  and  of placebo patients  out of  experienced a  reduction in tender and swollen joint counts and  of these  indicators blood test that measures inflammation patient assessment physician assessment pain scale and disabilityfunctional questionnaire at  months  of xeljanz patients  out of  and  of placebo patients  out of  experienced the same results during this study patients did not take methotrexate at  months more than half of xeljanz patients could more easily complete daily activities such as getting dressed walking down stairs and gripping household items in the oral solo study a scale was used that defines ra disability as   mild   moderate to severe   greater disability at the study start xeljanz patients had a mean baseline score of  at  months xeljanz patients saw an improved score of  a statistically important difference and overall   out of  of xeljanz patients experienced an improvement ≥ on the health assessment questionnaire disability index haqdi that assesses the following categories dressing and grooming arising eating walking hygiene reach grip and common daily activities during this study patients did not take methotrexate xeljanz reduced joint pain and swelling caused by ra even without the use of methotrexate in the oral solo study at  weeks  of xeljanz patients  out of  and  of placebo patients  out of  experienced a  reduction in tender and swollen joint counts and  of these  indicators blood test that measures inflammation patient assessment physician assessment pain scale and disabilityfunctional questionnaire at  months  of xeljanz patients  out of  and  of placebo patients  out of  experienced the same results during this study patients did not take methotrexate at  months xeljanz patients experienced less joint damage progression than methotrexate patients based on two studies xeljanz was shown on xrays to help reduce further structural joint damage this included holes in the bones known as erosions and the narrowing of the space between the bones where cartilage has been lost in the oral start study xeljanz patients hadnt taken methotrexate prior to the study however xeljanz is only approved for use in patients for whom methotrexate did not work well at  months xeljanz patients got worse by  units of change on the modified total sharp score mtss scale while patients taking methotrexate worsened by  mtss measures joint damage progression in selected joints of the hands and feet the higher the amount of change in the mtss the more joint damage has progressed in the oral scan study patients who took xeljanz and methotrexate had less progression of joint damage after  months  than those who took a placebo and methotrexate  however the possibility was high enough that the difference between treatments may have been due to chance alone and not due to xeljanz so the results were not considered significant     patient testimonial pullquote within  to  weeks i began to notice a difference individual results may vary  alison xeljanz patient watch alison’s story safety  side effects serious infections close x serious infections serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have back next cancer and immune system problems close x cancer and immune system problems cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder back next tears perforation in the stomach or intestines close x tears perforation in the stomach or intestines tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits back next changes in certain lab test results close x changes in certain lab test results changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that back next what should i tell my healthcare provider before taking xeljanzxeljanz xr close x what should i tell my healthcare provider before taking xeljanzxeljanz xr what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these back next what are other possible side effects of xeljanzxeljanz xr close x what are other possible side effects of xeljanzxeljanz xr what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis these are not all of the possible side effects of xeljanzxeljanz xr please see the prescribing information including boxed warning and medication guide for additional information and complete details about xeljanz back next request more info about xeljanz sign up now important safety information  indication expand or collapse important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide ra pharma home about us management team board of directors scientific advisory board pipeline overview ra preclinical  discovery programs therapeutic areas our science overview extreme diversity™ platform partnership news  investors overview news  events presentations and publications stock information sec filings corporate governance investor faq contact us working at ra our work philosophy open positions     delivering the next generation of complement therapeutics rapharma® is a clinicalstage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system a critical component of the immune system news ra pharmaceuticals inc  cambridge park drive cambridge ma  google maps phone   inforapharmacom home about us management team board of directors scientific advisory board pipeline overview ra preclinical  discovery programs factor d inhibitor oral c inhibitor cs inhibitor therapeutic areas paroxysmal nocturnal hemoglobinuria pnh refractory generalized myasthenia gravis rmg lupus nephritis ln our science overview extreme diversity™ platform partnership news  investors overview news  events presentations and publications stock information sec filings corporate governance investor faq contact us working at ra our work philosophy open positions contact  ra pharmaceuticals inc all rights reserved • terms  conditions about ra pharmaceuticals inc rarx  investingcom x breaking news how would you best describe yourself individual investor institutional investor financial advisor active trader thank you   search website for  popular searches trending stocks  stock screener  sign insign up  recent alerts sign up to create alerts for instruments economic events and content by followed authors sign up already have an account sign in english uktürkçeenglish india‏العربية‏english canadaελληνικάenglish australiasvenskaenglish south africasuomideutschעבריתespañol españa語español méxico한국어françaisitalianonederlandsbahasa indonesiaportuguês portugalbahasa melayupolskiไทยportuguês brasiltiếng việtрусский ra pharmaceuticals inc rarx   nasdaq create alert create alert new create alert website as an alert notification to use this feature make sure you are signedin to your account mobile app to use this feature make sure you are signedin to your account make sure you are signedin with the same user profile condition price change volume earnings moves above moves below frequency once gains  loses gains loses  frequency recurring once volume exceeds frequency recurring once follow ra pharmas earnings for all future releases just for the upcoming release send me a reminder  trading day before delivery method website popup mobile app notifications email notifications status create manage my alerts  back add toremove from a portfolio my portfolio add to watchlist add position position added successfully to please name your holdings portfolio type buy sell date   amount price point value leverage          commission   create a new watchlist create create a new holdings portfolio add create  add another position close         closed currency in usd  disclaimer  after hours     gmt  realtime data type equity market united states isin usv  cusip v volume  bidask    days range    start trading now ra pharma    start trading now general     chart     streaming chart interactive chart news  analysis     news financials     financial summary income statement balance sheet cash flow ratios dividends earnings technical     technical analysis candlestick patterns consensus estimates forum     discussions recent sentiments user rankings overview profile historical data index component ra pharmaceuticals inc company profile   get an indepth profile of ra pharmaceuticals inc including a general overview of the companys business and key management as well as employee data and location and contact information industrybiotechnology  drugs sectorhealthcare employees equity typeord ra pharmaceuticals inc is a united statesbased clinicalstage biopharmaceutical company the company focuses on the development of therapeutics for diseases of complement dysregulation and a range of orphan indications it utilizes small molecules and peptide approaches to address pathological targets in the complement cascade it has leveraged the extreme diversity peptide chemistry platform to develop a portfolio of products that selectively inhibit the complement system and other immune targets its main program ra is a macrocyclic peptide inhibitor of complement component  c which is in phase i stage of development for the treatment of paroxysmal nocturnal hemoglobinuria pnh ra binds a site on the c protein to inhibit cleavage into ca and cb thereby preventing red blood cell lysis by inhibiting the production and assembly of the membrane attack complex mac ra is being developed as an alternative to eculizumab therapy for patients with pnh contact information address cambridge ma united states phone  fax  web rapharmacom loading top executives name age since title kerry black   executive director operations alonso ricardo   senior vice president of research  development jeffrey johnston   senior vice president chief medical officer douglas a treco   president chief executive officer cofounder director add a comment comment guidelines comment guidelines we encourage you to use comments to engage with users share your perspective and ask questions of authors and each other however in order to maintain the high level of discourse we’ve all come to value and expect please keep the following criteria in mind  enrich the conversation stay focused and on track only post material that’s relevant to the topic being discussed be respectful even negative opinions can be framed positively and diplomatically  use standard writing style include punctuation and upper and lower cases note spam andor promotional messages and links within a comment will be removed avoid profanity slander or personal attacks directed at an author or another user don’t monopolize the conversation we appreciate passion and conviction but we also believe strongly in giving everyone a chance to air their thoughts therefore in addition to civil interaction we expect commenters to offer their opinions succinctly and thoughtfully but not so repeatedly that others are annoyed or offended if we receive complaints about individuals who take over a thread or forum we reserve the right to ban them from the site without recourse only english comments will be allowed perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at investingcom’s discretion i have read investingcoms comments guidelines and agree to the terms described i agree   are you sure you want to delete this chart delete cancel     replace the attached chart with a new chart  replace cancel post post also to  please wait a minute before you try to comment again thanks for your comment please note that all comments are pending until approved by our moderators it may therefore take some time before it appears on our website  reply   show more comments  show more replies    are you sure you want to delete this chart delete cancel     replace the attached chart with a new chart  replace cancel post  please wait a minute before you try to comment again       report this comment i feel that this comment is spam offensive irrelevant submit comment flagged thank you your report has been sent to our moderators for review close add chart to comment cancel attach disclaimer fusion media would like to remind you that the data contained in this website is not necessarily realtime nor accurate all cfds stocks indexes futures and forex prices are not provided by exchanges but rather by market makers and so prices may not be accurate and may differ from the actual market price meaning prices are indicative and not appropriate for trading purposes therefore fusion media doesnt bear any responsibility for any trading losses you might incur as a result of using this data fusion media or anyone involved with fusion media will not accept any liability for loss or damage as a result of reliance on the information including data quotes charts and buysell signals contained within this website please be fully informed regarding the risks and costs associated with trading the financial markets it is one of the riskiest investment forms possible find a broker indices commodities forex bonds more categories tabs selectionindicescommoditiesforexbondsstocksetfscount selected applydwmmyymax sp  futures  nasdaq futures  dow   sp  vix  dax  nikkei   us dollar index  euro index  gold  silver  copper  crude oil wti  brent oil  natural gas  us cotton   us coffee c  eurusd  gbpusd  usdjpy  usdcad  audusd  usdcnh  ethusd  btcusd  us y yield  us y yield  us y yield  us y yield  us y tnote  us y tbond  euro bund  uk gilt  start trading today forexcommoditiesindicesstocks tabs selection forexcommoditiesindicesstocksbondsetfs count selected apply timeframe  min  mins  mins  mins hourly  hours daily weekly eurusd    summary strong buy moving averages buy  sell  indicators buy  sell  eurusd    summary strong buy moving averages buy  sell  indicators buy  sell  gbpusd    summary sell moving averages buy  sell  indicators buy  sell  usdjpy    summary neutral moving averages buy  sell  indicators buy  sell  audusd    summary buy moving averages buy  sell  indicators buy  sell  usdcad    summary strong sell moving averages buy  sell  indicators buy  sell  eurjpy    summary strong sell moving averages buy  sell  indicators buy  sell  eurchf    summary strong sell moving averages buy  sell  indicators buy  sell  gold futures  summary moving averages buy sell indicators buy sell silver futures  summary moving averages buy sell indicators buy sell copper futures  summary moving averages buy sell indicators buy sell crude oil wti futures  summary moving averages buy sell indicators buy sell brent oil futures  summary moving averages buy sell indicators buy sell natural gas futures  summary moving averages buy sell indicators buy sell us coffee c futures  summary moving averages buy sell indicators buy sell dow jones industrial averag  summary moving averages buy sell indicators buy sell nasdaq   summary moving averages buy sell indicators buy sell sp   summary moving averages buy sell indicators buy sell dax  summary moving averages buy sell indicators buy sell ftse   summary moving averages buy sell indicators buy sell cac   summary moving averages buy sell indicators buy sell nikkei   summary moving averages buy sell indicators buy sell apple inc  summary moving averages buy sell indicators buy sell alphabet inc class a  summary moving averages buy sell indicators buy sell bank of america corp  summary moving averages buy sell indicators buy sell jpmorgan chase  co  summary moving averages buy sell indicators buy sell exxon mobil corporation  summary moving averages buy sell indicators buy sell bp plc  summary moving averages buy sell indicators buy sell deutsche bank ag na on  summary moving averages buy sell indicators buy sell us year  summary moving averages buy sell indicators buy sell us year  summary moving averages buy sell indicators buy sell us year  summary moving averages buy sell indicators buy sell us year  summary moving averages buy sell indicators buy sell euro bund futures  summary moving averages buy sell indicators buy sell us  year tnote futures  summary moving averages buy sell indicators buy sell japan government bond futur  summary moving averages buy sell indicators buy sell uk gilt futures  summary moving averages buy sell indicators buy sell spdr dow jones industrial a  summary moving averages buy sell indicators buy sell ishares russell  growth  summary moving averages buy sell indicators buy sell ishares russell   summary moving averages buy sell indicators buy sell powershares qqq trust serie  summary moving averages buy sell indicators buy sell spdr sp   summary moving averages buy sell indicators buy sell proshares ultrashort sp  summary moving averages buy sell indicators buy sell proshares ultrashort qqq  summary moving averages buy sell indicators buy sell     eurusd  strong buy       gbpusd  sell       usdjpy  neutral       audusd  buy       usdcad  strong sell       eurjpy  strong sell       eurchf  strong sell       gold       silver       copper       crude oil wti       brent oil       natural gas       us coffee c       dow        nasdaq        sp        dax       ftse        cac        nikkei        apple       alphabet a       bank of america       jpmorgan       exxon mobil       bp       deutsche bank ag   start trading today recent quotes namepricechgchg   rarx  add to watchlist add to watchlist add to watchlist max  select where to add the results added successfully create portfolio apply create close   market movers most active gainers  losers    name last chg  vol     fb   m     aapl   m     adp   m     baba   m     nvda   m     amzn   m     googl   m     name last chg  vol     adp   m     tdc   m     siri   m     tsco   m     vz   m     orly   m     kim   m     name last chg  vol     ca   m     jci   m     ffiv   m     xl   m     whr   m     psa   m     ivz   m   promotions should you try trading new markets nadex webinars identify sell and buy market areas tuesday august    pm edt does your trading edge suck lets fix it thursday august    pm edt intraday indicator pivot point daily formula tuesday august    pm edt neurolinguistics programming  trading psychology tuesday august    pm edt sign up for free and get realtime alerts advanced portfolio features personalized charts fullysynced app continue with facebook continue with google or sign up with email ra pharma home about us management team board of directors scientific advisory board pipeline overview ra preclinical  discovery programs therapeutic areas our science overview extreme diversity™ platform partnership news  investors overview news  events presentations and publications stock information sec filings corporate governance investor faq contact us working at ra our work philosophy open positions     delivering the next generation of complement therapeutics rapharma® is a clinicalstage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system a critical component of the immune system news ra pharmaceuticals inc  cambridge park drive cambridge ma  google maps phone   inforapharmacom home about us management team board of directors scientific advisory board pipeline overview ra preclinical  discovery programs factor d inhibitor oral c inhibitor cs inhibitor therapeutic areas paroxysmal nocturnal hemoglobinuria pnh refractory generalized myasthenia gravis rmg lupus nephritis ln our science overview extreme diversity™ platform partnership news  investors overview news  events presentations and publications stock information sec filings corporate governance investor faq contact us working at ra our work philosophy open positions contact  ra pharmaceuticals inc all rights reserved • terms  conditions ra pharmaceuticals inc nasdaqrarx ra pharmaceuticals inc rarx product news news  stocknewscom     follow us stocktwits twitter ra pharmaceuticals inc rarx product news news rarx – announces initial data from the global phase  clinical program evaluating ra for the treatment of paroxysmal nocturnal hemoglobinuria jun    am  by stocknewscom staff product news key facts surrounding this news item rarx had returned  yeartodate leading up to today’s news versus a  return from the benchmark sp  during the same period more info about ra pharmaceuticals inc rarx ra pharmaceuticals inc a clinicalstage biopharmaceutical company engages in the discovery and development of novel therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system its peptide chemistry platform delivers enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules the company was founded in  and is based in cambridge massachusetts view our full rarx ticker page with ratings news and more rarx at a glance rarx current powr rating™ overall powr rating™ rarx current price   more rarx ratings data and news rarx price reaction the day of this event jun  rarx closing price rarx volume from avgleading up to this eventrarx mo returnnaafter this eventrarx day returnrarx day returnrarx day return rarx price chart more ra pharmaceuticals inc rarx news view all eventdate symbol news detail start price end price change powr rating loading please wait view all rarx news page generated in  seconds safety info  is xeljanz® tofacitinib citrate or xeljanz xr® tofacitinib citrate right for you skip to main content home menu menu register for info menu scroll up to unhide the main menu home about xeljanz frequently asked questions frequently asked questions what is xeljanzxeljanz xr xeljanzxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children scroll for important safety information important safety information what is the most important information i should know about xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide   you are now leaving xeljanzcom links to other sites are provided as a convenience to the visitor pfizer accepts no responsibility for the content of linked sites would you like to continue yes no   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm close x copay card terms and conditions by using the xeljanz® xr tofacitinib citrate extended releasexeljanz® tofacitinib citrate instant copay savings card the “card” you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions the card is not valid for prescriptions that are eligible to be reimbursed in whole or in part by medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan available in puerto rico formerly known as “la reforma de salud” the card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription drugs you will receive a maximum benefit of  per calendar year which is defined by the date of enrollment through december st of the enrollment year with a  per month copay after a maximum of  you will be responsible for paying the remaining monthly outofpocket costs the card may be used once per month for the life of the program you must deduct the value received under this program from any reimbursement request submitted to your insurance plan either directly by you or on your behalf cannot be combined with any other rebatecoupon free trial or similar offer for the specified prescription the card will be accepted only at participating pharmacies the card is not health insurance offer good only in the us and puerto rico the card is limited to  per person during this offering period and is not transferable pfizer reserves the right to rescind revoke or amend the program without notice no membership fee card and program expires  if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide close x important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide close x what is xeljanzxeljanz xr xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children continue to site scroll for more information popup prescribing information medication guide close x xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well now available xeljanz is now available as a oncedaily pill called xeljanz xr ask your doctor if xeljanz xr is right for you important safety information and indication what is the most important information i should know about xeljanz® tofacitinib citratexeljanz® xr tofacitinib citrate xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide ppxelusa   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no close x trial rx program terms and conditions this is not health insurance and is a onetimeonly offer for eligible commercially insured patients offer is only available to patients who have been diagnosed with an fdaapproved indication for xeljanz® xr tofacitinib citrate extended release patients who have already begun therapy with xeljanz xr at the time of the request and patients under the age of eighteen  years of age are ineligible for participation in the program no claim for reimbursement for product dispensed pursuant to this offer may be submitted to any thirdparty private payer not available to patients covered under government plans such as medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan or for residents of massachusetts available in a day supply this offer does not require nor will be made contingent on purchase requirements of any kind pfizer reserves the right to amend rescind or discontinue this program at any time without notification trial rx can only be dispensed by the exclusive pharmacy and only after benefits investigation has been completed additional eligibility criteria may apply contact xelsource for details if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide the difference between xeljanz  xeljanz xr the difference is the dosage—xeljanz xr is the oncedaily formulation of xeljanz if youre currently taking xeljanz but are interested in a oncedaily treatment talk with your doctor about xeljanz xr learn more about the two with the chart below treatment xeljanz xeljanz xr how its taken how its taken twicedaily pill oncedaily pill dosage dosage  mg per pill  mg per pill how its delivered how its delivered immediate release tablet that releases medication into the bloodstream over the course of several hours extended release tablet that releases medication into the bloodstream over the course of a day can be taken without methotrexate can be taken without methotrexate yes yes xeljanz xr tablets should be swallowed whole and intact do not crush split or chew about xeljanz  xeljanz xr expand all  how can i learn if xeljanzxeljanz xr is right for me xeljanzxeljanz xr is a medication called a janus kinase jak inhibitor it is used to treat adults with moderately to severely active rheumatoid arthritis ra in which methotrexate did not work well your healthcare provider can help determine if xeljanz or oncedaily xeljanz xr is right for you for more information see is xeljanz for you what is a jak inhibitor and why does it matter for me xeljanzxeljanz xr is the first in a new class of treatments for moderate to severe ra called janus kinase jak inhibitors jak inhibitors work deep inside the cell to disrupt cellular activities that occur in signaling pathways known as the jak pathways learn more about the different treatment options and where xeljanz fits into the mix how soon will i notice a difference when taking xeljanz in some patients xeljanz can begin to work in as early as  weeks to help relieve joint pain and swelling and in clinical trials more than half of xeljanz patients felt an improvement in ra symptoms at  months everybody is different though so your results may differ learn more about how xeljanz performed in clinical trial results does xeljanz help reduce the progression of joint damage xeljanz has been shown to be effective in slowing the progression of joint damage in a clinical trial at  months xeljanz reduced joint damage progression better than methotrexate in the oral start study xeljanz patients hadnt taken methotrexate prior to the study however xeljanz is only approved for use in patients for whom methotrexate did not work well at  months xeljanz patients got worse by  units of change on the modified total sharp score mtss scale while patients taking methotrexate worsened by  mtss measures joint damage progression in selected joints of the hands and feet the higher the amount of change in the mtss the more joint damage has progressed in the oral scan study patients who took xeljanz and methotrexate had less progression of joint damage after  months  than those who took a placebo and methotrexate  however the possibility was high enough that the difference between treatments may have been due to chance alone and not due to xeljanz so the results were not considered significant learn how the progression of ra causes joint damage what are the active ingredients in xeljanzxeljanz xr the active ingredient in xeljanzxeljanz xr is tofacitinib citrate what laboratory tests are necessary with xeljanzxeljanz xr your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that i do not want to take methotrexate can xeljanzxeljanz xr work alone xeljanzxeljanz xr is proven to work alone—even without methotrexate xeljanz a jak inhibitor has been shown to help reduce pain and swelling in the joints and to slow the progression of joint damage can xeljanzxeljanz xr be taken with a biologic treatment no xeljanzxeljanz xr cannot be taken with a biologic treatment be sure to tell your healthcare provider about all the medicines you take for more information see rheumatoid arthritis ra treatment options how do i take xeljanzxeljanz xr—does it require injections or infusions xeljanzxeljanz xr is taken by mouth xeljanz is taken twice daily while xeljanz xr is taken once daily xeljanzxeljanz xr can be taken with or without food for more information see what is xeljanz if i’m taking xeljanz xr will i see something in my stool when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what information is important to know when taking xeljanzxeljanz xr take xeljanzxeljanz xr as prescribed by your healthcare provider if you take too much xeljanzxeljanz xr call your healthcare provider or go to the nearest hospital emergency room right away you should also take into account the following safety advice keep xeljanzxeljanz xr and all medicines out of the reach of children do not use xeljanzxeljanz xr for a condition for which it was not prescribed do not give xeljanzxeljanz xr to other people even if they have the same symptoms you have it may harm them for more information see safety  side effects what should i do if i miss a dose contact your healthcare provider if you miss a dose or forget to take xeljanzxeljanz xr for an extended period of time what should i do if i am not getting the results i expected keep in mind that everybody is different if you are not getting the results you expected talk with your healthcare provider together you can determine if changing your course of treatment might be an appropriate step to help you determine how xeljanz is working see tracking your progress what are some tips for remembering to take xeljanzxeljanz xr create daily reminders—by using your mobile phone or sticky notes—to help you stay on track when you register for the xeljanzyou support program you’ll receive sticky notes and other helpful items like an rafriendly water bottle as a free gift set up alerts to remind you when it’s time to take xeljanzxeljanz xr take xeljanz with your morning and evening meals or before or after you brush your teeth take oncedaily xeljanz xr only in the morning or only in the evening about safety expand all  what are the serious side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including serious infections cancer and immune system problems tears perforation in the stomach or intestines and changes in certain laboratory test results these are not all the possible side effects of xeljanzxeljanz xr to read more see safety  side effects what are common side effects of xeljanzxeljanz xr the common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea nasal congestion sore throat and runny nose nasopharyngitis these are not all the possible side effects of xeljanzxeljanz xr to read more see safety  side effects what should i do if i experience side effects tell your healthcare provider about any side effects you are experiencing you may report side effects to the fda at fda you may also report side effects to pfizer at  can i take xeljanzxeljanz xr if i am pregnant or planning to have a baby before starting xeljanzxeljanz xr be sure to talk with your healthcare provider if you are pregnant or plan to become pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll for more information see safety  side effects should i take xeljanzxeljanz xr if i am breastfeeding or plan to breastfeed before starting xeljanzxeljanz xr you and your healthcare provider should decide if you will take xeljanzxeljanz xr or breastfeed you should not do both learn about real patient experiences with xeljanz watch alison’s story important safety information  indication expand or collapse important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide safety info  is xeljanz® tofacitinib citrate or xeljanz xr® tofacitinib citrate right for you skip to main content home menu menu register for info menu scroll up to unhide the main menu home about xeljanz frequently asked questions frequently asked questions what is xeljanzxeljanz xr xeljanzxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children scroll for important safety information important safety information what is the most important information i should know about xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide   you are now leaving xeljanzcom links to other sites are provided as a convenience to the visitor pfizer accepts no responsibility for the content of linked sites would you like to continue yes no   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm i confirm that i have read the important safety information and indication for xeljanz and wish to continue to the video confirm close x copay card terms and conditions by using the xeljanz® xr tofacitinib citrate extended releasexeljanz® tofacitinib citrate instant copay savings card the “card” you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions the card is not valid for prescriptions that are eligible to be reimbursed in whole or in part by medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan available in puerto rico formerly known as “la reforma de salud” the card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs which reimburse you for the entire cost of your prescription drugs you will receive a maximum benefit of  per calendar year which is defined by the date of enrollment through december st of the enrollment year with a  per month copay after a maximum of  you will be responsible for paying the remaining monthly outofpocket costs the card may be used once per month for the life of the program you must deduct the value received under this program from any reimbursement request submitted to your insurance plan either directly by you or on your behalf cannot be combined with any other rebatecoupon free trial or similar offer for the specified prescription the card will be accepted only at participating pharmacies the card is not health insurance offer good only in the us and puerto rico the card is limited to  per person during this offering period and is not transferable pfizer reserves the right to rescind revoke or amend the program without notice no membership fee card and program expires  if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide close x important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide close x what is xeljanzxeljanz xr xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children continue to site scroll for more information popup prescribing information medication guide close x xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well now available xeljanz is now available as a oncedaily pill called xeljanz xr ask your doctor if xeljanz xr is right for you important safety information and indication what is the most important information i should know about xeljanz® tofacitinib citratexeljanz® xr tofacitinib citrate xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide ppxelusa   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no   you are now leaving this pfizer site your app store will open to download the signal swipe app pfizer accepts no responsibility for the content of linked sites would you like to continue yes no close x trial rx program terms and conditions this is not health insurance and is a onetimeonly offer for eligible commercially insured patients offer is only available to patients who have been diagnosed with an fdaapproved indication for xeljanz® xr tofacitinib citrate extended release patients who have already begun therapy with xeljanz xr at the time of the request and patients under the age of eighteen  years of age are ineligible for participation in the program no claim for reimbursement for product dispensed pursuant to this offer may be submitted to any thirdparty private payer not available to patients covered under government plans such as medicaid medicare or other federal or state healthcare programs including any state prescription drug assistance programs and the government health insurance plan or for residents of massachusetts available in a day supply this offer does not require nor will be made contingent on purchase requirements of any kind pfizer reserves the right to amend rescind or discontinue this program at any time without notification trial rx can only be dispensed by the exclusive pharmacy and only after benefits investigation has been completed additional eligibility criteria may apply contact xelsource for details if you have questions or are in need of additional support call  or visit wwwxeljanzcom pfizer inc  e nd street new york ny  please see full prescribing information including boxed warning and medication guide the difference between xeljanz  xeljanz xr the difference is the dosage—xeljanz xr is the oncedaily formulation of xeljanz if youre currently taking xeljanz but are interested in a oncedaily treatment talk with your doctor about xeljanz xr learn more about the two with the chart below treatment xeljanz xeljanz xr how its taken how its taken twicedaily pill oncedaily pill dosage dosage  mg per pill  mg per pill how its delivered how its delivered immediate release tablet that releases medication into the bloodstream over the course of several hours extended release tablet that releases medication into the bloodstream over the course of a day can be taken without methotrexate can be taken without methotrexate yes yes xeljanz xr tablets should be swallowed whole and intact do not crush split or chew about xeljanz  xeljanz xr expand all  how can i learn if xeljanzxeljanz xr is right for me xeljanzxeljanz xr is a medication called a janus kinase jak inhibitor it is used to treat adults with moderately to severely active rheumatoid arthritis ra in which methotrexate did not work well your healthcare provider can help determine if xeljanz or oncedaily xeljanz xr is right for you for more information see is xeljanz for you what is a jak inhibitor and why does it matter for me xeljanzxeljanz xr is the first in a new class of treatments for moderate to severe ra called janus kinase jak inhibitors jak inhibitors work deep inside the cell to disrupt cellular activities that occur in signaling pathways known as the jak pathways learn more about the different treatment options and where xeljanz fits into the mix how soon will i notice a difference when taking xeljanz in some patients xeljanz can begin to work in as early as  weeks to help relieve joint pain and swelling and in clinical trials more than half of xeljanz patients felt an improvement in ra symptoms at  months everybody is different though so your results may differ learn more about how xeljanz performed in clinical trial results does xeljanz help reduce the progression of joint damage xeljanz has been shown to be effective in slowing the progression of joint damage in a clinical trial at  months xeljanz reduced joint damage progression better than methotrexate in the oral start study xeljanz patients hadnt taken methotrexate prior to the study however xeljanz is only approved for use in patients for whom methotrexate did not work well at  months xeljanz patients got worse by  units of change on the modified total sharp score mtss scale while patients taking methotrexate worsened by  mtss measures joint damage progression in selected joints of the hands and feet the higher the amount of change in the mtss the more joint damage has progressed in the oral scan study patients who took xeljanz and methotrexate had less progression of joint damage after  months  than those who took a placebo and methotrexate  however the possibility was high enough that the difference between treatments may have been due to chance alone and not due to xeljanz so the results were not considered significant learn how the progression of ra causes joint damage what are the active ingredients in xeljanzxeljanz xr the active ingredient in xeljanzxeljanz xr is tofacitinib citrate what laboratory tests are necessary with xeljanzxeljanz xr your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that i do not want to take methotrexate can xeljanzxeljanz xr work alone xeljanzxeljanz xr is proven to work alone—even without methotrexate xeljanz a jak inhibitor has been shown to help reduce pain and swelling in the joints and to slow the progression of joint damage can xeljanzxeljanz xr be taken with a biologic treatment no xeljanzxeljanz xr cannot be taken with a biologic treatment be sure to tell your healthcare provider about all the medicines you take for more information see rheumatoid arthritis ra treatment options how do i take xeljanzxeljanz xr—does it require injections or infusions xeljanzxeljanz xr is taken by mouth xeljanz is taken twice daily while xeljanz xr is taken once daily xeljanzxeljanz xr can be taken with or without food for more information see what is xeljanz if i’m taking xeljanz xr will i see something in my stool when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what information is important to know when taking xeljanzxeljanz xr take xeljanzxeljanz xr as prescribed by your healthcare provider if you take too much xeljanzxeljanz xr call your healthcare provider or go to the nearest hospital emergency room right away you should also take into account the following safety advice keep xeljanzxeljanz xr and all medicines out of the reach of children do not use xeljanzxeljanz xr for a condition for which it was not prescribed do not give xeljanzxeljanz xr to other people even if they have the same symptoms you have it may harm them for more information see safety  side effects what should i do if i miss a dose contact your healthcare provider if you miss a dose or forget to take xeljanzxeljanz xr for an extended period of time what should i do if i am not getting the results i expected keep in mind that everybody is different if you are not getting the results you expected talk with your healthcare provider together you can determine if changing your course of treatment might be an appropriate step to help you determine how xeljanz is working see tracking your progress what are some tips for remembering to take xeljanzxeljanz xr create daily reminders—by using your mobile phone or sticky notes—to help you stay on track when you register for the xeljanzyou support program you’ll receive sticky notes and other helpful items like an rafriendly water bottle as a free gift set up alerts to remind you when it’s time to take xeljanzxeljanz xr take xeljanz with your morning and evening meals or before or after you brush your teeth take oncedaily xeljanz xr only in the morning or only in the evening about safety expand all  what are the serious side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including serious infections cancer and immune system problems tears perforation in the stomach or intestines and changes in certain laboratory test results these are not all the possible side effects of xeljanzxeljanz xr to read more see safety  side effects what are common side effects of xeljanzxeljanz xr the common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea nasal congestion sore throat and runny nose nasopharyngitis these are not all the possible side effects of xeljanzxeljanz xr to read more see safety  side effects what should i do if i experience side effects tell your healthcare provider about any side effects you are experiencing you may report side effects to the fda at fda you may also report side effects to pfizer at  can i take xeljanzxeljanz xr if i am pregnant or planning to have a baby before starting xeljanzxeljanz xr be sure to talk with your healthcare provider if you are pregnant or plan to become pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll for more information see safety  side effects should i take xeljanzxeljanz xr if i am breastfeeding or plan to breastfeed before starting xeljanzxeljanz xr you and your healthcare provider should decide if you will take xeljanzxeljanz xr or breastfeed you should not do both learn about real patient experiences with xeljanz watch alison’s story important safety information  indication expand or collapse important safety information what is the most important information i should know about xeljanz® tofacitinib citrate  mg tabletsxeljanz® xr tofacitinib citrate extended release  mg tablets xeljanzxeljanz xr may cause serious side effects including serious infections xeljanzxeljanz xr can lower the ability of your immune system to fight infections some people can have serious infections while taking xeljanzxeljanz xr including tuberculosis tb and infections caused by bacteria fungi or viruses that can spread throughout the body some people have died from these infections your healthcare provider should test you for tb before starting xeljanzxeljanz xr and monitor you closely for signs and symptoms of tb infection during treatment you should not start taking xeljanzxeljanz xr if you have any kind of infection unless your healthcare provider tells you it is okay you may be at a higher risk of developing shingles before starting xeljanzxeljanz xr tell your healthcare provider if you think you have an infection or have symptoms of an infection such as fever sweating or chills cough blood in phlegm warm red or painful skin or sores on your body burning when you urinate or urinating more often than normal muscle aches shortness of breath weight loss diarrhea or stomach pain or feeling very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes hiv or a weak immune system people with these conditions have a higher chance for infections have tb or have been in close contact with someone with tb live or have lived in or have traveled to certain parts of the country such as the ohio and mississippi river valleys and the southwest where there is an increased chance for getting certain kinds of fungal infections histoplasmosis coccidioidomycosis or blastomycosis these infections may happen or become more severe if you use xeljanzxeljanz xr ask your healthcare provider if you do not know if you have lived in an area where these infections are common have or have had hepatitis b or c after starting xeljanzxeljanz xr call your healthcare provider right away if you have any symptoms of an infection xeljanzxeljanz xr can make you more likely to get infections or make worse any infection that you have cancer and immune system problems xeljanzxeljanz xr may increase your risk of certain cancers by changing the way your immune system works lymphoma and other cancers including skin cancers have happened in patients taking xeljanzxeljanz xr tell your healthcare provider if you have ever had any type of cancer some people who have taken xeljanz with certain other medicines to prevent kidney transplant rejection have had a problem with certain white blood cells growing out of control epstein barr virus–associated posttransplant lymphoproliferative disorder tears perforation in the stomach or intestines some people taking xeljanzxeljanz xr can get tears in their stomach or intestine this happens most often in people who also take nonsteroidal antiinflammatory drugs nsaids corticosteroids or methotrexate tell your healthcare provider right away if you have fever and stomacharea pain that does not go away and a change in your bowel habits changes in certain lab test results your healthcare provider should do blood tests before you start receiving xeljanzxeljanz xr and while you take xeljanzxeljanz xr to check for the following side effects changes in lymphocyte counts lymphocytes are white blood cells that help the body fight off infections low neutrophil counts neutrophils are white blood cells that help the body fight off infections low red blood cell count this may mean that you have anemia which may make you feel weak and tired your healthcare provider should routinely check certain liver tests you should not receive xeljanzxeljanz xr if your lymphocyte count neutrophil count or red blood cell count is too low or your liver tests are too high your healthcare provider may stop your xeljanzxeljanz xr treatment for a period of time if needed because of changes in these blood test results your healthcare provider should do blood tests to check your cholesterol levels  weeks after you start xeljanzxeljanz xr and as needed after that what should i tell my healthcare provider before taking xeljanzxeljanz xr xeljanzxeljanz xr may not be right for you before taking xeljanzxeljanz xr tell your healthcare provider if you have an infection have liver problems have kidney problems have any stomach area abdominal pain or been diagnosed with diverticulitis inflammation in parts of the large intestine or ulcers in your stomach or intestines or narrowing within your digestive tract have had a reaction to tofacitinib or any of the ingredients in xeljanzxeljanz xr have recently received or are scheduled to receive a vaccine people taking xeljanzxeljanz xr should not receive live vaccines but can receive nonlive vaccines have any other medical conditions plan to become pregnant or are pregnant it is not known if xeljanzxeljanz xr will harm an unborn baby pregnancy registry pfizer has a registry for pregnant women who take xeljanzxeljanz xr the purpose of this registry is to check the health of the pregnant mother and her baby if you are pregnant or become pregnant while taking xeljanzxeljanz xr talk to your healthcare provider about how you can join this pregnancy registry or you may contact the registry at  to enroll plan to breastfeed or are breastfeeding tell your healthcare provider about all of the medicines you take especially any other medicines to treat your rheumatoid arthritis you should not take tocilizumab actemra® etanercept enbrel® adalimumab humira® infliximab remicade® rituximab rituxan® abatacept orencia® anakinra kineret® certolizumab pegol cimzia® golimumab simponi® azathioprine cyclosporine or other immunosuppressive drugs while you are taking xeljanzxeljanz xr taking xeljanz or xeljanz xr with these medicines may increase your risk of infection tell your healthcare provider if you are taking medicines that affect the way certain liver enzymes work ask your healthcare provider if you are not sure if your medicine is one of these taking xeljanz xr when you take xeljanz xr you may see something in your stool that looks like a tablet this is the empty shell from the tablet after the medicine has been absorbed by your body what are other possible side effects of xeljanzxeljanz xr xeljanzxeljanz xr may cause serious side effects including hepatitis b or c activation infection in people who carry the virus in their blood if you are a carrier of the hepatitis b or c virus viruses that affect the liver the virus may become active while you use xeljanzxeljanz xr tell your healthcare provider if you have the following symptoms of a possible hepatitis b or c infection feel very tired little or no appetite claycolored bowel movements chills muscle aches skin rash skin or eyes look yellow vomiting fevers stomach discomfort or dark urine common side effects of xeljanzxeljanz xr include upper respiratory tract infections common cold sinus infections headache diarrhea and nasal congestion sore throat and runny nose nasopharyngitis what is xeljanzxeljanz xr xeljanzxeljanz xr is a prescription medicine called a janus kinase jak inhibitor xeljanzxeljanz xr is used to treat adults with moderately to severely active rheumatoid arthritis in which methotrexate did not work well it is not known if xeljanzxeljanz xr is safe and effective in people with hepatitis b or c xeljanzxeljanz xr is not for people with severe liver problems it is not known if xeljanzxeljanz xr is safe and effective in children please see full prescribing information including boxed warning and medication guide